Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-378a-3p ACTB 1.47 0.04667 -0.79 0.01089 miRNAWalker2 validate -0.11 0 NA
2 hsa-let-7a-3p AMOT 0.83 0.04681 -1.94 0.20701 mirMAP -0.59 0.00568 NA
3 hsa-let-7f-1-3p AMOT 1.62 0.00069 -1.94 0.20701 mirMAP -1.03 0 NA
4 hsa-miR-203a-3p AMOT 6.35 0 -1.94 0.20701 MirTarget -0.4 0 NA
5 hsa-miR-205-5p AMOT 8.08 0 -1.94 0.20701 MirTarget; miRNATAP -0.39 0 26239614 MicroRNA 205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression; In the present study miR-205 was significantly downregulated in breast cancer samples and it was identified to directly target the 3'-untranslated region 3'-UTR of AMOT in breast cancer MCF-7 cells by luciferase assay; miR-205 and small interfering RNA siRNA-mediated AMOT-knockdown experiments revealed that miR-205 significantly inhibited the proliferation and the invasion of MCF-7 cells through a decrease in the expression of AMOT yet had no effect on apoptosis; Furthermore we observed that the overexpression of AMOT partially reversed the inhibitory effect of miR-205 on the growth and the invasion of MCF-7 cells; The data indicated that miR-205 regulated the proliferation and the invasion of breast cancer cells through suppression of AMOT expression at least partly; Therefore the disordered decreased expression of miR-205 and the resulting AMOT upregulation contributes to breast carcinogenesis and miR-205-AMOT represents a new potential therapeutic target for the treatment of breast carcinoma
6 hsa-miR-21-3p AMOT 3.5 0 -1.94 0.20701 mirMAP -0.74 0 NA
7 hsa-miR-212-3p AMOT 0.74 0.2589 -1.94 0.20701 MirTarget -0.43 0.00122 NA
8 hsa-miR-22-3p AMOT 0.85 0.01489 -1.94 0.20701 MirTarget; miRNATAP -1.19 0 NA
9 hsa-miR-221-3p AMOT 0.94 0.17475 -1.94 0.20701 miRNAWalker2 validate -0.85 0 NA
10 hsa-miR-2355-3p AMOT 0.49 0.48372 -1.94 0.20701 MirTarget; miRNATAP -0.72 0 NA
11 hsa-miR-29a-3p AMOT -0.64 0.25192 -1.94 0.20701 MirTarget; miRNATAP -0.56 0.00034 NA
12 hsa-miR-29b-3p AMOT 0.67 0.23406 -1.94 0.20701 MirTarget; miRNATAP -0.59 0.00013 NA
13 hsa-miR-330-3p AMOT 2.49 0.00013 -1.94 0.20701 MirTarget; PITA; miRNATAP -0.63 0 NA
14 hsa-miR-330-5p AMOT 2.25 0.00028 -1.94 0.20701 miRanda -0.64 0 NA
15 hsa-miR-342-3p AMOT 1.31 0.02072 -1.94 0.20701 miRanda -0.68 1.0E-5 NA
16 hsa-miR-34c-3p AMOT 4.04 0.0002 -1.94 0.20701 MirTarget; mirMAP -0.25 0.00175 NA
17 hsa-miR-34c-5p AMOT 2.65 0.01574 -1.94 0.20701 miRanda -0.23 0.00315 NA
18 hsa-miR-944 AMOT 7.21 0.00082 -1.94 0.20701 mirMAP; miRNATAP -0.38 0 NA
19 hsa-miR-186-5p APC 0.45 0.18545 -0.08 0.84234 miRNAWalker2 validate -0.19 0.00487 NA
20 hsa-miR-30a-3p APC -1.22 0.16757 -0.08 0.84234 MirTarget; miRNATAP -0.11 1.0E-5 NA
21 hsa-miR-320b APC 0.2 0.72722 -0.08 0.84234 miRanda -0.12 0.00135 NA
22 hsa-miR-374b-5p APC -0.11 0.76489 -0.08 0.84234 mirMAP -0.19 0.00128 NA
23 hsa-miR-590-3p APC 2.35 0 -0.08 0.84234 PITA; miRanda; mirMAP; miRNATAP -0.17 0.0001 NA
24 hsa-miR-7-1-3p APC 1.43 0.00471 -0.08 0.84234 MirTarget -0.15 0.00061 NA
25 hsa-miR-125a-5p APC2 -1.32 0.00714 3.13 0.00737 mirMAP -0.85 0 NA
26 hsa-miR-194-3p APC2 1.92 0.10538 3.13 0.00737 mirMAP -0.16 0.00507 NA
27 hsa-miR-28-5p APC2 -0.82 0.02212 3.13 0.00737 mirMAP -0.67 0.00043 NA
28 hsa-let-7a-3p AXIN2 0.83 0.04681 -3.82 0.00033 miRNATAP -0.49 0.00085 NA
29 hsa-let-7b-3p AXIN2 0.59 0.20051 -3.82 0.00033 miRNATAP -0.5 0.00019 NA
30 hsa-let-7f-2-3p AXIN2 1.03 0.07873 -3.82 0.00033 MirTarget -0.36 0.00084 NA
31 hsa-miR-15a-5p AXIN2 2.05 0 -3.82 0.00033 MirTarget; miRNATAP -0.55 8.0E-5 26252081 The combination of miR-15a and AXIN2 significantly improved the diagnostic accuracy
32 hsa-miR-15b-5p AXIN2 3.32 0 -3.82 0.00033 miRTarBase; MirTarget; miRNATAP -0.47 0.00022 NA
33 hsa-miR-16-2-3p AXIN2 3.8 0 -3.82 0.00033 mirMAP -0.68 0 NA
34 hsa-miR-16-5p AXIN2 2.94 0 -3.82 0.00033 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.7 0 NA
35 hsa-miR-205-5p AXIN2 8.08 0 -3.82 0.00033 miRNATAP -0.3 0 NA
36 hsa-miR-221-3p AXIN2 0.94 0.17475 -3.82 0.00033 miRNATAP -0.52 0 NA
37 hsa-miR-222-3p AXIN2 1.55 0.0223 -3.82 0.00033 miRNATAP -0.53 0 NA
38 hsa-miR-3614-5p AXIN2 4.5 0 -3.82 0.00033 MirTarget; miRNATAP -0.26 0.00012 NA
39 hsa-miR-590-3p AXIN2 2.35 0 -3.82 0.00033 MirTarget; PITA; miRanda; miRNATAP -0.5 3.0E-5 NA
40 hsa-miR-944 AXIN2 7.21 0.00082 -3.82 0.00033 MirTarget; PITA; miRNATAP -0.28 0 NA
41 hsa-miR-139-5p BBC3 -2.09 0.00038 0.48 0.3579 miRNATAP -0.16 0.00143 NA
42 hsa-miR-101-3p BIRC5 -1.12 0.02009 6.15 0 miRNAWalker2 validate -0.2 0.0054 NA
43 hsa-miR-106a-5p BMP2 3.99 0 0.6 0.59614 miRNATAP -0.28 0.0002 NA
44 hsa-miR-362-3p BMP2 0.68 0.22615 0.6 0.59614 miRanda -0.39 0.0006 NA
45 hsa-miR-378c BMP2 0.45 0.49938 0.6 0.59614 miRNATAP -0.28 0.0034 NA
46 hsa-miR-429 BMP2 6.4 0 0.6 0.59614 miRNATAP -0.32 0.00011 NA
47 hsa-miR-142-3p BMP4 4.35 0 -1.95 0.0822 PITA; miRanda -0.38 2.0E-5 NA
48 hsa-miR-590-3p BMP4 2.35 0 -1.95 0.0822 miRanda -0.37 0.00319 NA
49 hsa-miR-125a-3p BMP7 -0.07 0.92074 2.47 0.14183 miRanda -0.6 0 NA
50 hsa-miR-30a-5p BMP7 -0.77 0.32049 2.47 0.14183 mirMAP; miRNATAP -0.84 0 NA
51 hsa-miR-338-3p BMP7 0.45 0.55849 2.47 0.14183 miRanda -0.68 0 NA
52 hsa-miR-142-3p BMP8A 4.35 0 -0.91 0.14941 miRNAWalker2 validate -0.15 0.00247 NA
53 hsa-miR-30e-3p BMP8A -0.04 0.93258 -0.91 0.14941 MirTarget -0.27 0.00121 NA
54 hsa-miR-326 BMP8A 1.77 0.03673 -0.91 0.14941 miRanda -0.12 0.00459 NA
55 hsa-miR-125a-5p BMP8B -1.32 0.00714 2.55 0.00041 miRanda -0.22 0.00973 NA
56 hsa-miR-26b-5p BMP8B 0.31 0.46163 2.55 0.00041 miRNAWalker2 validate -0.34 0.00051 NA
57 hsa-miR-455-5p BMP8B -0.32 0.6163 2.55 0.00041 miRanda -0.19 0.00365 NA
58 hsa-miR-142-5p BMPR1B 3.96 0 -1.52 0.34339 mirMAP -0.73 0 NA
59 hsa-miR-146b-5p BMPR1B 1.88 0.00074 -1.52 0.34339 miRanda -0.67 4.0E-5 NA
60 hsa-miR-150-5p BMPR1B 1.77 0.05938 -1.52 0.34339 MirTarget -0.47 0 NA
61 hsa-miR-205-5p BMPR1B 8.08 0 -1.52 0.34339 miRNATAP -0.31 0 NA
62 hsa-miR-23b-3p BMPR1B -0.58 0.19048 -1.52 0.34339 mirMAP -0.74 0.00035 NA
63 hsa-miR-24-3p BMPR1B 1.56 0.00052 -1.52 0.34339 miRNATAP -0.55 0.00635 NA
64 hsa-miR-374a-5p BMPR1B 0.28 0.45888 -1.52 0.34339 MirTarget -0.88 0.00036 NA
65 hsa-miR-590-3p BMPR1B 2.35 0 -1.52 0.34339 miRanda; mirMAP -0.55 0.00205 NA
66 hsa-miR-629-3p BMPR1B 3.48 0 -1.52 0.34339 MirTarget -0.42 0.00285 NA
67 hsa-let-7f-1-3p BMPR2 1.62 0.00069 -1.13 0.00109 MirTarget -0.12 0.00286 NA
68 hsa-miR-106b-5p BMPR2 2.81 0 -1.13 0.00109 MirTarget; miRNATAP -0.12 0.00443 NA
69 hsa-miR-146b-3p BMPR2 1.35 0.00936 -1.13 0.00109 MirTarget; PITA -0.13 0.00059 NA
70 hsa-miR-148b-3p BMPR2 1.76 0 -1.13 0.00109 mirMAP -0.2 0.00099 NA
71 hsa-miR-16-2-3p BMPR2 3.8 0 -1.13 0.00109 mirMAP -0.15 6.0E-5 NA
72 hsa-miR-17-5p BMPR2 2.33 2.0E-5 -1.13 0.00109 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -0.12 0.00049 NA
73 hsa-miR-19b-3p BMPR2 1.68 0.00086 -1.13 0.00109 miRNAWalker2 validate; MirTarget; miRNATAP -0.15 0.0001 NA
74 hsa-miR-20a-5p BMPR2 2.14 0.00018 -1.13 0.00109 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.11 0.00126 NA
75 hsa-miR-25-3p BMPR2 1.13 0.00311 -1.13 0.00109 miRNATAP -0.16 0.00181 NA
76 hsa-miR-30b-5p BMPR2 0.02 0.95322 -1.13 0.00109 mirMAP -0.17 0.00068 NA
77 hsa-miR-30e-5p BMPR2 0.78 0.03467 -1.13 0.00109 mirMAP -0.15 0.00461 NA
78 hsa-miR-32-5p BMPR2 2.93 0 -1.13 0.00109 miRNATAP -0.15 0.00016 NA
79 hsa-miR-590-3p BMPR2 2.35 0 -1.13 0.00109 MirTarget; miRanda; mirMAP; miRNATAP -0.18 0 NA
80 hsa-miR-590-5p BMPR2 1.51 0.00239 -1.13 0.00109 MirTarget; PITA; miRNATAP -0.15 0.00015 NA
81 hsa-miR-92a-3p BMPR2 1.88 1.0E-5 -1.13 0.00109 miRNAWalker2 validate; miRNATAP -0.2 1.0E-5 NA
82 hsa-miR-93-3p BMPR2 2.63 0 -1.13 0.00109 miRNAWalker2 validate -0.11 0.00334 NA
83 hsa-miR-93-5p BMPR2 2.66 0 -1.13 0.00109 miRNAWalker2 validate; MirTarget; miRNATAP -0.13 0.00184 NA
84 hsa-let-7e-5p BTRC -0.11 0.81474 -0.39 0.22952 miRNAWalker2 validate -0.16 4.0E-5 NA
85 hsa-miR-125a-3p BTRC -0.07 0.92074 -0.39 0.22952 miRanda -0.11 0 NA
86 hsa-miR-15b-5p BTRC 3.32 0 -0.39 0.22952 MirTarget; miRNATAP -0.14 0.00015 NA
87 hsa-miR-16-5p BTRC 2.94 0 -0.39 0.22952 miRNAWalker2 validate; MirTarget; miRNATAP -0.13 0.00072 NA
88 hsa-miR-28-5p BTRC -0.82 0.02212 -0.39 0.22952 miRanda -0.24 0 NA
89 hsa-miR-339-5p BTRC 1.23 0.03075 -0.39 0.22952 MirTarget; miRanda -0.11 0.00101 NA
90 hsa-miR-3913-5p BTRC 0.15 0.73484 -0.39 0.22952 mirMAP -0.16 0.00018 NA
91 hsa-miR-505-3p BTRC 0.59 0.22694 -0.39 0.22952 MirTarget -0.1 0.00592 NA
92 hsa-let-7a-5p CCND1 0.15 0.64531 0.15 0.87753 TargetScan; miRNATAP -0.54 0.00245 NA
93 hsa-miR-106a-5p CCND1 3.99 0 0.15 0.87753 MirTarget; miRNATAP -0.43 0 NA
94 hsa-miR-15a-5p CCND1 2.05 0 0.15 0.87753 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.35 0.00776 22922827 CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR
95 hsa-miR-15b-5p CCND1 3.32 0 0.15 0.87753 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.42 0.00029 NA
96 hsa-miR-20b-5p CCND1 4.57 5.0E-5 0.15 0.87753 MirTarget; miRNATAP -0.31 0 NA
97 hsa-miR-34a-5p CCND1 0.83 0.04775 0.15 0.87753 miRNAWalker2 validate; miRTarBase; miRNATAP -0.42 0.00174 25792709; 21399894 This inhibition of proliferation was associated with a decrease in cyclin D1 levels orchestrated principally by HNF-4α a target of miR-34a considered to act as a tumour suppressor in the liver;Quantitative PCR and western analysis confirmed decreased expression of two genes BCL-2 and CCND1 in docetaxel-resistant cells which are both targeted by miR-34a
98 hsa-miR-497-5p CCND1 -1.44 0.02251 0.15 0.87753 MirTarget; miRNATAP -0.25 0.00498 21350001 Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer
99 hsa-miR-106a-5p CCND2 3.99 0 -2.81 0.0014 miRNATAP -0.44 0 NA
100 hsa-miR-106b-5p CCND2 2.81 0 -2.81 0.0014 miRNAWalker2 validate; miRTarBase; miRNATAP -0.31 0.00374 NA
101 hsa-miR-10a-3p CCND2 0.97 0.31667 -2.81 0.0014 mirMAP -0.2 0.00011 NA
102 hsa-miR-130b-5p CCND2 3.74 0 -2.81 0.0014 mirMAP -0.46 0 NA
103 hsa-miR-141-3p CCND2 7.3 0 -2.81 0.0014 MirTarget; TargetScan -0.24 0.00021 NA
104 hsa-miR-15b-5p CCND2 3.32 0 -2.81 0.0014 miRNATAP -0.53 0 NA
105 hsa-miR-16-2-3p CCND2 3.8 0 -2.81 0.0014 mirMAP -0.29 0.00207 NA
106 hsa-miR-182-5p CCND2 5.87 0 -2.81 0.0014 miRNAWalker2 validate; miRTarBase; miRNATAP -0.28 2.0E-5 NA
107 hsa-miR-183-5p CCND2 6.62 0 -2.81 0.0014 miRNATAP -0.29 0 NA
108 hsa-miR-191-5p CCND2 1.59 0.00074 -2.81 0.0014 MirTarget -0.32 0.00314 NA
109 hsa-miR-200a-3p CCND2 6.34 0 -2.81 0.0014 MirTarget -0.41 0 NA
110 hsa-miR-20b-5p CCND2 4.57 5.0E-5 -2.81 0.0014 miRNATAP -0.3 0 NA
111 hsa-miR-224-3p CCND2 2.85 0.00018 -2.81 0.0014 mirMAP -0.22 0.00101 NA
112 hsa-miR-28-5p CCND2 -0.82 0.02212 -2.81 0.0014 miRanda -0.43 0.00273 NA
113 hsa-miR-3065-3p CCND2 1.89 0.03082 -2.81 0.0014 MirTarget; miRNATAP -0.21 0.00027 NA
114 hsa-miR-3065-5p CCND2 2.14 0.06094 -2.81 0.0014 mirMAP -0.2 0.00026 NA
115 hsa-miR-30d-3p CCND2 -0.07 0.85742 -2.81 0.0014 mirMAP -0.55 1.0E-5 NA
116 hsa-miR-324-3p CCND2 1.51 0.00384 -2.81 0.0014 miRNAWalker2 validate -0.44 0 NA
117 hsa-miR-33a-3p CCND2 2.06 0.00156 -2.81 0.0014 MirTarget -0.27 0.00041 NA
118 hsa-miR-378a-3p CCND2 1.47 0.04667 -2.81 0.0014 miRNAWalker2 validate -0.19 0.00601 NA
119 hsa-miR-429 CCND2 6.4 0 -2.81 0.0014 miRNATAP -0.46 0 NA
120 hsa-miR-497-5p CCND2 -1.44 0.02251 -2.81 0.0014 MirTarget; miRNATAP -0.27 0.00058 NA
121 hsa-miR-550a-5p CCND2 1.22 0.06138 -2.81 0.0014 MirTarget -0.22 0.00363 NA
122 hsa-miR-660-5p CCND2 -0.07 0.88525 -2.81 0.0014 mirMAP -0.29 0.00793 NA
123 hsa-miR-9-3p CCND2 1.69 0.12517 -2.81 0.0014 MirTarget; mirMAP; miRNATAP -0.14 0.00185 NA
124 hsa-miR-93-5p CCND2 2.66 0 -2.81 0.0014 miRNATAP -0.48 0 NA
125 hsa-miR-96-5p CCND2 5.63 0 -2.81 0.0014 TargetScan; miRNATAP -0.24 0.0003 NA
126 hsa-miR-27b-3p CCND3 -0.09 0.85847 -0.54 0.12437 miRNAWalker2 validate -0.14 0.00019 NA
127 hsa-miR-429 CCND3 6.4 0 -0.54 0.12437 miRNATAP -0.11 1.0E-5 NA
128 hsa-miR-96-5p CCND3 5.63 0 -0.54 0.12437 TargetScan -0.12 1.0E-5 NA
129 hsa-let-7b-5p CRB2 -0.19 0.65188 -2.32 0.05811 miRNATAP -0.46 0.00608 NA
130 hsa-miR-16-2-3p CTGF 3.8 0 -4.34 2.0E-5 MirTarget -0.74 0 NA
131 hsa-miR-18a-5p CTGF 3.91 0 -4.34 2.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.47 0 23249750 Targeting of TGFβ signature and its essential component CTGF by miR 18 correlates with improved survival in glioblastoma; Indeed microRNA-18a but not other miR-17∼92 members has a functional site in the CTGF 3' UTR and its forced reexpression sharply reduces CTGF protein and mRNA levels; The unexpected effects of miR-18a on CTGF transcription are mediated in part by direct targeting of Smad3 and ensuing weakening of TGFβ signaling
132 hsa-miR-19a-3p CTGF 2.17 0.00122 -4.34 2.0E-5 MirTarget; miRNATAP -0.48 0 NA
133 hsa-miR-19b-3p CTGF 1.68 0.00086 -4.34 2.0E-5 MirTarget; miRNATAP -0.63 0 NA
134 hsa-miR-205-5p CTGF 8.08 0 -4.34 2.0E-5 miRNAWalker2 validate; miRTarBase -0.25 0 NA
135 hsa-miR-330-3p CTGF 2.49 0.00013 -4.34 2.0E-5 MirTarget; PITA; miRNATAP -0.27 0.00261 NA
136 hsa-miR-486-5p CTGF 1.11 0.30929 -4.34 2.0E-5 miRanda -0.14 0.00686 NA
137 hsa-miR-590-3p CTGF 2.35 0 -4.34 2.0E-5 PITA; miRanda -0.39 0.00059 NA
138 hsa-miR-140-5p CTNNA1 -0.63 0.12667 0.14 0.59553 miRanda -0.13 0.00029 NA
139 hsa-miR-150-5p CTNNB1 1.77 0.05938 -0.6 0.15222 MirTarget -0.12 0 NA
140 hsa-miR-155-5p CTNNB1 2.81 7.0E-5 -0.6 0.15222 miRNAWalker2 validate -0.17 0 NA
141 hsa-miR-221-3p CTNNB1 0.94 0.17475 -0.6 0.15222 miRNAWalker2 validate -0.15 1.0E-5 NA
142 hsa-miR-330-3p CTNNB1 2.49 0.00013 -0.6 0.15222 MirTarget; PITA; miRNATAP -0.11 0.00159 NA
143 hsa-miR-590-3p CTNNB1 2.35 0 -0.6 0.15222 miRanda -0.16 0.00059 NA
144 hsa-miR-146b-5p DLG1 1.88 0.00074 0.98 0.01314 MirTarget; miRanda -0.14 0.00052 NA
145 hsa-miR-186-5p DLG1 0.45 0.18545 0.98 0.01314 MirTarget; mirMAP; miRNATAP -0.25 0.00032 NA
146 hsa-miR-320b DLG1 0.2 0.72722 0.98 0.01314 miRanda -0.1 0.00732 NA
147 hsa-let-7g-3p DLG2 2.1 5.0E-5 -4.94 0.00023 miRNATAP -0.46 0.00167 NA
148 hsa-miR-130a-3p DLG2 0.18 0.75775 -4.94 0.00023 miRNATAP -0.46 0.0006 NA
149 hsa-miR-130a-5p DLG2 1.58 0.02435 -4.94 0.00023 MirTarget; miRNATAP -0.49 1.0E-5 NA
150 hsa-miR-135b-5p DLG2 4.81 0 -4.94 0.00023 MirTarget -0.43 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 CANONICAL WNT SIGNALING PATHWAY 28 95 5.866e-43 2.73e-39
2 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 61 1672 5.379e-40 1.251e-36
3 ORGAN MORPHOGENESIS 48 841 5.083e-39 7.884e-36
4 WNT SIGNALING PATHWAY 36 351 1.124e-37 1.307e-34
5 TISSUE DEVELOPMENT 57 1518 1.817e-37 1.691e-34
6 EPITHELIUM DEVELOPMENT 48 945 1.204e-36 9.334e-34
7 REGULATION OF PROTEIN MODIFICATION PROCESS 58 1710 7.948e-36 5.283e-33
8 TISSUE MORPHOGENESIS 38 533 7.83e-34 4.554e-31
9 REGULATION OF PHOSPHORUS METABOLIC PROCESS 55 1618 1.246e-33 6.443e-31
10 REGULATION OF WNT SIGNALING PATHWAY 32 310 1.971e-33 9.172e-31
11 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 46 1021 1.265e-32 5.351e-30
12 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 29 236 1.737e-32 6.734e-30
13 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 47 1142 1.177e-31 4.213e-29
14 EMBRYONIC MORPHOGENESIS 36 539 6.037e-31 2.006e-28
15 REGULATION OF CELL DIFFERENTIATION 51 1492 7.349e-31 2.28e-28
16 POSITIVE REGULATION OF RESPONSE TO STIMULUS 56 1929 9.045e-31 2.63e-28
17 POSITIVE REGULATION OF GENE EXPRESSION 53 1733 6.807e-30 1.863e-27
18 CELL FATE COMMITMENT 27 227 7.921e-30 2.048e-27
19 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 50 1492 9.438e-30 2.311e-27
20 TUBE DEVELOPMENT 35 552 2.879e-29 6.698e-27
21 NEUROGENESIS 48 1402 8.529e-29 1.804e-26
22 RESPONSE TO GROWTH FACTOR 33 475 8.191e-29 1.804e-26
23 MORPHOGENESIS OF AN EPITHELIUM 31 400 1.799e-28 3.488e-26
24 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 39 801 1.795e-28 3.488e-26
25 POSITIVE REGULATION OF CELL COMMUNICATION 49 1532 3.896e-28 7.251e-26
26 EMBRYO DEVELOPMENT 40 894 7.438e-28 1.331e-25
27 CARDIOVASCULAR SYSTEM DEVELOPMENT 38 788 1.541e-27 2.561e-25
28 CIRCULATORY SYSTEM DEVELOPMENT 38 788 1.541e-27 2.561e-25
29 NEGATIVE REGULATION OF CELL COMMUNICATION 44 1192 1.952e-27 3.133e-25
30 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 43 1135 3.367e-27 5.222e-25
31 POSITIVE REGULATION OF CELL DIFFERENTIATION 38 823 7.472e-27 1.122e-24
32 REGULATION OF CELL DEATH 47 1472 8.748e-27 1.272e-24
33 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 51 1848 1.845e-26 2.602e-24
34 REGULATION OF ORGAN MORPHOGENESIS 25 242 4.785e-26 6.548e-24
35 SENSORY ORGAN DEVELOPMENT 31 493 1.07e-25 1.422e-23
36 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 22 162 1.213e-25 1.568e-23
37 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 39 957 1.323e-25 1.664e-23
38 REGULATION OF CARTILAGE DEVELOPMENT 17 63 1.843e-25 2.256e-23
39 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 23 197 3.146e-25 3.753e-23
40 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 44 1360 4.335e-25 5.043e-23
41 NEURON DIFFERENTIATION 37 874 8.905e-25 1.011e-22
42 REGULATION OF CELL PROLIFERATION 45 1496 2.024e-24 2.243e-22
43 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 39 1036 2.412e-24 2.55e-22
44 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 39 1036 2.412e-24 2.55e-22
45 REGULATION OF CELL DEVELOPMENT 36 836 2.56e-24 2.647e-22
46 CELL DEVELOPMENT 44 1426 2.959e-24 2.993e-22
47 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 48 1805 6.092e-24 6.031e-22
48 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 30 513 6.261e-24 6.069e-22
49 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 38 1008 1.076e-23 1.022e-21
50 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 43 1395 1.271e-23 1.183e-21
51 REGULATION OF CELLULAR PROTEIN LOCALIZATION 30 552 5.231e-23 4.712e-21
52 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 37 983 5.266e-23 4.712e-21
53 EMBRYONIC ORGAN DEVELOPMENT 27 406 5.622e-23 4.936e-21
54 CELL PROLIFERATION 32 672 7.981e-23 6.877e-21
55 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 39 1152 1.125e-22 9.52e-21
56 REGULATION OF STEM CELL DIFFERENTIATION 18 113 2.129e-22 1.769e-20
57 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 29 554 8.959e-22 7.313e-20
58 TUBE MORPHOGENESIS 24 323 1.435e-21 1.151e-19
59 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 14 50 2.221e-21 1.751e-19
60 POSITIVE REGULATION OF CELL DEVELOPMENT 27 472 2.927e-21 2.27e-19
61 STEM CELL DIFFERENTIATION 20 190 4.437e-21 3.384e-19
62 RESPONSE TO ENDOGENOUS STIMULUS 41 1450 5.16e-21 3.872e-19
63 POSITIVE REGULATION OF CELL DEATH 29 605 1.023e-20 7.555e-19
64 NON CANONICAL WNT SIGNALING PATHWAY 18 140 1.207e-20 8.778e-19
65 NEGATIVE REGULATION OF CELL DIFFERENTIATION 29 609 1.226e-20 8.779e-19
66 EPITHELIAL TO MESENCHYMAL TRANSITION 14 56 1.341e-20 9.456e-19
67 CARTILAGE DEVELOPMENT 18 147 2.991e-20 2.077e-18
68 REGULATION OF OSSIFICATION 19 178 3.559e-20 2.435e-18
69 CELLULAR COMPONENT MORPHOGENESIS 33 900 4.773e-20 3.219e-18
70 NEGATIVE REGULATION OF CELL PROLIFERATION 29 643 5.441e-20 3.617e-18
71 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 12 34 7.005e-20 4.591e-18
72 REGULATION OF MAPK CASCADE 29 660 1.109e-19 7.17e-18
73 MESENCHYME DEVELOPMENT 19 190 1.251e-19 7.869e-18
74 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 19 190 1.251e-19 7.869e-18
75 CONNECTIVE TISSUE DEVELOPMENT 19 194 1.867e-19 1.158e-17
76 MESENCHYMAL CELL DIFFERENTIATION 17 134 1.934e-19 1.184e-17
77 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 14 67 2.162e-19 1.307e-17
78 SKELETAL SYSTEM DEVELOPMENT 25 455 2.864e-19 1.708e-17
79 REGULATION OF OSTEOBLAST DIFFERENTIATION 16 112 3.324e-19 1.958e-17
80 HIPPO SIGNALING 11 27 3.791e-19 2.2e-17
81 GROWTH 24 410 3.829e-19 2.2e-17
82 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 17 141 4.722e-19 2.679e-17
83 EMBRYONIC ORGAN MORPHOGENESIS 21 279 4.846e-19 2.717e-17
84 HEART DEVELOPMENT 25 466 5.075e-19 2.811e-17
85 EYE DEVELOPMENT 22 326 6.713e-19 3.675e-17
86 UROGENITAL SYSTEM DEVELOPMENT 21 299 2.024e-18 1.095e-16
87 GASTRULATION 17 155 2.453e-18 1.297e-16
88 REGULATION OF PROTEIN LOCALIZATION 32 950 2.453e-18 1.297e-16
89 GLAND DEVELOPMENT 23 395 2.615e-18 1.367e-16
90 PATTERN SPECIFICATION PROCESS 23 418 9.133e-18 4.722e-16
91 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 41 1784 9.776e-18 4.998e-16
92 REGULATION OF EPITHELIAL CELL PROLIFERATION 20 285 1.451e-17 7.336e-16
93 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 18 207 1.545e-17 7.73e-16
94 REGULATION OF EMBRYONIC DEVELOPMENT 15 114 1.666e-17 8.248e-16
95 REGULATION OF TRANSFERASE ACTIVITY 31 946 2.068e-17 1.013e-15
96 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 21 337 2.34e-17 1.134e-15
97 HEART MORPHOGENESIS 18 212 2.371e-17 1.137e-15
98 OSSIFICATION 19 251 2.463e-17 1.169e-15
99 REGULATION OF CELL MORPHOGENESIS 25 552 2.815e-17 1.323e-15
100 EPITHELIAL CELL DIFFERENTIATION 24 495 2.881e-17 1.34e-15
101 CELL JUNCTION ORGANIZATION 17 185 5.128e-17 2.362e-15
102 REGULATION OF KINASE ACTIVITY 28 776 8.986e-17 4.099e-15
103 HEAD DEVELOPMENT 27 709 9.359e-17 4.228e-15
104 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 15 131 1.425e-16 6.374e-15
105 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 17 197 1.492e-16 6.549e-15
106 RESPIRATORY SYSTEM DEVELOPMENT 17 197 1.492e-16 6.549e-15
107 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 12 60 1.606e-16 6.984e-15
108 NEGATIVE REGULATION OF CELL DEATH 29 872 1.94e-16 8.356e-15
109 MORPHOGENESIS OF A BRANCHING STRUCTURE 16 167 2.331e-16 9.952e-15
110 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 38 1656 2.65e-16 1.121e-14
111 POSITIVE REGULATION OF OSSIFICATION 13 84 2.913e-16 1.221e-14
112 REGULATION OF CHONDROCYTE DIFFERENTIATION 11 46 3.586e-16 1.49e-14
113 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 27 750 3.774e-16 1.554e-14
114 NEGATIVE REGULATION OF GENE EXPRESSION 36 1493 4.646e-16 1.896e-14
115 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 15 144 6.039e-16 2.423e-14
116 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 11 48 6.023e-16 2.423e-14
117 MESONEPHROS DEVELOPMENT 13 90 7.463e-16 2.968e-14
118 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 36 1517 7.654e-16 3.018e-14
119 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 30 1004 9.355e-16 3.658e-14
120 RESPONSE TO BMP 13 94 1.346e-15 5.175e-14
121 CELLULAR RESPONSE TO BMP STIMULUS 13 94 1.346e-15 5.175e-14
122 VASCULATURE DEVELOPMENT 22 469 1.447e-15 5.518e-14
123 POSITIVE REGULATION OF MAPK CASCADE 22 470 1.512e-15 5.674e-14
124 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 22 470 1.512e-15 5.674e-14
125 REGULATION OF APOPTOTIC SIGNALING PATHWAY 20 363 1.567e-15 5.833e-14
126 REGULATION OF CELLULAR LOCALIZATION 33 1277 1.587e-15 5.86e-14
127 REGULATION OF CELL CYCLE 29 949 1.773e-15 6.496e-14
128 KIDNEY EPITHELIUM DEVELOPMENT 14 125 2.136e-15 7.765e-14
129 POSITIVE REGULATION OF CELL PROLIFERATION 27 814 2.822e-15 1.018e-13
130 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 15 162 3.582e-15 1.282e-13
131 SMAD PROTEIN SIGNAL TRANSDUCTION 11 56 3.84e-15 1.364e-13
132 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 14 135 6.383e-15 2.25e-13
133 DEVELOPMENTAL INDUCTION 9 27 6.449e-15 2.256e-13
134 FORMATION OF PRIMARY GERM LAYER 13 110 1.109e-14 3.852e-13
135 REPRODUCTIVE SYSTEM DEVELOPMENT 20 408 1.443e-14 4.975e-13
136 REGIONALIZATION 18 311 2.015e-14 6.892e-13
137 BLOOD VESSEL MORPHOGENESIS 19 364 2.294e-14 7.792e-13
138 MAMMARY GLAND DEVELOPMENT 13 117 2.516e-14 8.484e-13
139 LENS DEVELOPMENT IN CAMERA TYPE EYE 11 66 2.657e-14 8.896e-13
140 REGULATION OF INTRACELLULAR TRANSPORT 23 621 4.633e-14 1.54e-12
141 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 29 1087 5.807e-14 1.916e-12
142 DEVELOPMENTAL GROWTH 18 333 6.532e-14 2.14e-12
143 OSTEOBLAST DIFFERENTIATION 13 126 6.688e-14 2.176e-12
144 SENSORY ORGAN MORPHOGENESIS 16 239 6.785e-14 2.192e-12
145 REGULATION OF GROWTH 23 633 6.926e-14 2.222e-12
146 SKELETAL SYSTEM MORPHOGENESIS 15 201 8.877e-14 2.829e-12
147 CELL JUNCTION ASSEMBLY 13 129 9.11e-14 2.884e-12
148 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 12 100 1.022e-13 3.214e-12
149 POSITIVE REGULATION OF MOLECULAR FUNCTION 36 1791 1.259e-13 3.931e-12
150 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 13 134 1.499e-13 4.649e-12
151 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 14 171 1.754e-13 5.404e-12
152 RESPONSE TO LIPID 26 888 1.866e-13 5.712e-12
153 CELLULAR MACROMOLECULE LOCALIZATION 30 1234 2.15e-13 6.497e-12
154 MESENCHYME MORPHOGENESIS 9 38 2.143e-13 6.497e-12
155 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 9 39 2.774e-13 8.328e-12
156 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 15 218 2.922e-13 8.716e-12
157 POSITIVE REGULATION OF KINASE ACTIVITY 20 482 3.257e-13 9.59e-12
158 KIDNEY MORPHOGENESIS 11 82 3.242e-13 9.59e-12
159 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 15 220 3.339e-13 9.773e-12
160 APICAL JUNCTION ASSEMBLY 9 40 3.565e-13 1.037e-11
161 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 22 616 3.722e-13 1.076e-11
162 STEM CELL PROLIFERATION 10 60 4.181e-13 1.201e-11
163 REGULATION OF ORGANELLE ORGANIZATION 29 1178 4.409e-13 1.258e-11
164 REGULATION OF PROTEIN IMPORT 14 183 4.477e-13 1.27e-11
165 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 8 26 4.622e-13 1.303e-11
166 PALATE DEVELOPMENT 11 85 4.879e-13 1.368e-11
167 NEGATIVE REGULATION OF CELL CYCLE 19 433 5.103e-13 1.422e-11
168 NEPHRON DEVELOPMENT 12 115 5.64e-13 1.562e-11
169 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 15 229 5.991e-13 1.649e-11
170 REGULATION OF STEM CELL PROLIFERATION 11 88 7.229e-13 1.979e-11
171 LOCOMOTION 28 1114 7.502e-13 2.041e-11
172 MESODERM DEVELOPMENT 12 118 7.708e-13 2.085e-11
173 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 13 154 9.127e-13 2.455e-11
174 NEGATIVE REGULATION OF GROWTH 15 236 9.277e-13 2.481e-11
175 CENTRAL NERVOUS SYSTEM DEVELOPMENT 25 872 9.511e-13 2.529e-11
176 CELLULAR RESPONSE TO RETINOIC ACID 10 65 9.724e-13 2.571e-11
177 ANTERIOR POSTERIOR PATTERN SPECIFICATION 14 194 9.982e-13 2.624e-11
178 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 25 876 1.052e-12 2.75e-11
179 MESODERM MORPHOGENESIS 10 66 1.141e-12 2.967e-11
180 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 8 29 1.254e-12 3.242e-11
181 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 17 360 3.039e-12 7.644e-11
182 REGULATION OF ORGAN FORMATION 8 32 3.035e-12 7.644e-11
183 APPENDAGE DEVELOPMENT 13 169 3.012e-12 7.644e-11
184 BICELLULAR TIGHT JUNCTION ASSEMBLY 8 32 3.035e-12 7.644e-11
185 LIMB DEVELOPMENT 13 169 3.012e-12 7.644e-11
186 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 22 689 3.43e-12 8.58e-11
187 REGULATION OF CELLULAR RESPONSE TO STRESS 22 691 3.631e-12 9.034e-11
188 CELL CELL JUNCTION ASSEMBLY 10 74 3.759e-12 9.304e-11
189 RESPONSE TO OXYGEN CONTAINING COMPOUND 30 1381 3.821e-12 9.407e-11
190 IN UTERO EMBRYONIC DEVELOPMENT 16 311 3.867e-12 9.47e-11
191 REGULATION OF CELLULAR COMPONENT MOVEMENT 23 771 4.085e-12 9.951e-11
192 ODONTOGENESIS 11 105 5.245e-12 1.271e-10
193 MAMMARY GLAND EPITHELIUM DEVELOPMENT 9 53 5.474e-12 1.313e-10
194 MESONEPHRIC TUBULE MORPHOGENESIS 9 53 5.474e-12 1.313e-10
195 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 18 437 6.431e-12 1.53e-10
196 RENAL TUBULE DEVELOPMENT 10 78 6.476e-12 1.53e-10
197 RESPONSE TO RETINOIC ACID 11 107 6.469e-12 1.53e-10
198 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 20 573 7.707e-12 1.811e-10
199 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 11 110 8.791e-12 2.056e-10
200 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 7 22 1.087e-11 2.529e-10
201 REGULATION OF BINDING 15 283 1.261e-11 2.919e-10
202 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 8 38 1.377e-11 3.171e-10
203 NEGATIVE REGULATION OF MOLECULAR FUNCTION 26 1079 1.535e-11 3.519e-10
204 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 12 152 1.597e-11 3.642e-10
205 REGULATION OF DEVELOPMENTAL GROWTH 15 289 1.699e-11 3.857e-10
206 CHONDROCYTE DIFFERENTIATION 9 60 1.774e-11 3.987e-10
207 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 9 60 1.774e-11 3.987e-10
208 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 20 602 1.875e-11 4.195e-10
209 RESPONSE TO ORGANIC CYCLIC COMPOUND 24 917 1.999e-11 4.451e-10
210 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 7 24 2.188e-11 4.847e-10
211 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 6 13 2.379e-11 5.247e-10
212 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 19 541 2.477e-11 5.412e-10
213 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 19 541 2.477e-11 5.412e-10
214 RHYTHMIC PROCESS 15 298 2.625e-11 5.707e-10
215 REGULATION OF JNK CASCADE 12 159 2.716e-11 5.879e-10
216 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 11 122 2.753e-11 5.931e-10
217 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 20 616 2.83e-11 6.069e-10
218 NEGATIVE REGULATION OF CELL DEVELOPMENT 15 303 3.32e-11 7.087e-10
219 PROTEIN PHOSPHORYLATION 24 944 3.648e-11 7.75e-10
220 NEPHRON EPITHELIUM DEVELOPMENT 10 93 3.907e-11 8.264e-10
221 CELL CYCLE 28 1316 3.959e-11 8.336e-10
222 REGULATION OF PROTEIN TARGETING 15 307 3.996e-11 8.375e-10
223 POSITIVE REGULATION OF CATALYTIC ACTIVITY 30 1518 4.058e-11 8.467e-10
224 REGULATION OF CELL ADHESION 20 629 4.109e-11 8.535e-10
225 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 16 365 4.27e-11 8.83e-10
226 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 8 44 4.866e-11 9.975e-10
227 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 10 95 4.846e-11 9.975e-10
228 SKIN DEVELOPMENT 13 211 4.998e-11 1.02e-09
229 REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 27 5.544e-11 1.126e-09
230 CELL ACTIVATION 19 568 5.699e-11 1.153e-09
231 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 16 381 8.063e-11 1.624e-09
232 EYE MORPHOGENESIS 11 136 9.014e-11 1.808e-09
233 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 18 514 9.253e-11 1.848e-09
234 REGULATION OF RESPONSE TO STRESS 29 1468 9.552e-11 1.899e-09
235 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 27 1275 1.077e-10 2.132e-09
236 ORGAN INDUCTION 6 16 1.097e-10 2.163e-09
237 REGULATION OF ORGAN GROWTH 9 73 1.104e-10 2.167e-09
238 PROTEIN LOCALIZATION 32 1805 1.238e-10 2.42e-09
239 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 7 30 1.255e-10 2.444e-09
240 CELLULAR RESPONSE TO LIPID 17 457 1.289e-10 2.499e-09
241 CELL DIVISION 17 460 1.426e-10 2.753e-09
242 RESPONSE TO ABIOTIC STIMULUS 24 1024 1.931e-10 3.714e-09
243 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 14 289 2.105e-10 4.03e-09
244 DIGESTIVE SYSTEM DEVELOPMENT 11 148 2.25e-10 4.292e-09
245 REGULATION OF HYDROLASE ACTIVITY 27 1327 2.631e-10 4.996e-09
246 REGULATION OF NEURON DIFFERENTIATION 18 554 3.104e-10 5.871e-09
247 REGULATION OF KIDNEY DEVELOPMENT 8 55 3.194e-10 6.017e-09
248 REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 34 3.263e-10 6.122e-09
249 POSITIVE REGULATION OF LOCOMOTION 16 420 3.373e-10 6.302e-09
250 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 9 84 3.998e-10 7.442e-09
251 CARDIAC SEPTUM DEVELOPMENT 9 85 4.453e-10 8.255e-09
252 EPIDERMIS DEVELOPMENT 13 253 4.744e-10 8.76e-09
253 EMBRYONIC PATTERN SPECIFICATION 8 58 4.967e-10 9.134e-09
254 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 36 5.022e-10 9.199e-09
255 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 6 20 5.223e-10 9.531e-09
256 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 7 37 6.168e-10 1.117e-08
257 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 7 37 6.168e-10 1.117e-08
258 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 20 740 7.148e-10 1.289e-08
259 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 13 262 7.281e-10 1.308e-08
260 CELL DEATH 23 1001 7.315e-10 1.309e-08
261 MIDBRAIN DEVELOPMENT 9 90 7.482e-10 1.334e-08
262 REGULATION OF MAP KINASE ACTIVITY 14 319 7.647e-10 1.358e-08
263 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 21 829 8.081e-10 1.43e-08
264 REPRODUCTION 26 1297 8.429e-10 1.486e-08
265 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 9 93 1.006e-09 1.767e-08
266 TUBE FORMATION 10 129 1.024e-09 1.791e-08
267 PHOSPHORYLATION 25 1228 1.404e-09 2.447e-08
268 GLAND MORPHOGENESIS 9 97 1.471e-09 2.553e-08
269 REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 43 1.883e-09 3.258e-08
270 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 15 406 1.923e-09 3.315e-08
271 CAMERA TYPE EYE MORPHOGENESIS 9 101 2.114e-09 3.629e-08
272 INTRACELLULAR SIGNAL TRANSDUCTION 28 1572 2.297e-09 3.929e-08
273 REGULATION OF CYTOPLASMIC TRANSPORT 16 481 2.391e-09 4.076e-08
274 REGULATION OF MUSCLE TISSUE DEVELOPMENT 9 103 2.519e-09 4.262e-08
275 REGULATION OF MUSCLE ORGAN DEVELOPMENT 9 103 2.519e-09 4.262e-08
276 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 8 71 2.612e-09 4.388e-08
277 REGULATION OF TRANSPORT 30 1804 2.607e-09 4.388e-08
278 ANGIOGENESIS 13 293 2.832e-09 4.741e-08
279 CARDIAC CHAMBER DEVELOPMENT 10 144 3.003e-09 5.009e-08
280 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 6 26 3.028e-09 5.031e-08
281 CELL CYCLE PROCESS 23 1081 3.197e-09 5.293e-08
282 NEGATIVE REGULATION OF PHOSPHORYLATION 15 422 3.249e-09 5.361e-08
283 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 8 75 4.074e-09 6.699e-08
284 DIGESTIVE TRACT MORPHOGENESIS 7 48 4.216e-09 6.907e-08
285 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 14 368 4.807e-09 7.847e-08
286 VENTRICULAR SEPTUM MORPHOGENESIS 6 28 4.914e-09 7.967e-08
287 CARDIAC SEPTUM MORPHOGENESIS 7 49 4.898e-09 7.967e-08
288 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 14 370 5.15e-09 8.321e-08
289 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 31 1977 5.316e-09 8.56e-08
290 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 10 153 5.407e-09 8.676e-08
291 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 29 6.171e-09 9.766e-08
292 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 29 6.171e-09 9.766e-08
293 STEM CELL DIVISION 6 29 6.171e-09 9.766e-08
294 REGULATION OF HEART MORPHOGENESIS 6 29 6.171e-09 9.766e-08
295 REGULATION OF DEPHOSPHORYLATION 10 158 7.376e-09 1.163e-07
296 RESPONSE TO ACID CHEMICAL 13 319 7.857e-09 1.235e-07
297 CELL CELL SIGNALING 19 767 8.378e-09 1.308e-07
298 REGULATION OF CELLULAR COMPONENT BIOGENESIS 19 767 8.378e-09 1.308e-07
299 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 7 53 8.646e-09 1.345e-07
300 SEX DIFFERENTIATION 12 266 9.979e-09 1.548e-07
301 SINGLE ORGANISM CELL ADHESION 15 459 1.006e-08 1.555e-07
302 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 15 465 1.196e-08 1.842e-07
303 ENDOCRINE SYSTEM DEVELOPMENT 9 123 1.216e-08 1.867e-07
304 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 5 16 1.242e-08 1.895e-07
305 PARAXIAL MESODERM DEVELOPMENT 5 16 1.242e-08 1.895e-07
306 REGULATION OF PROTEIN BINDING 10 168 1.33e-08 2.023e-07
307 RESPONSE TO ESTROGEN 11 218 1.35e-08 2.046e-07
308 ESTABLISHMENT OF CELL POLARITY 8 88 1.471e-08 2.222e-07
309 REGULATION OF PROTEIN STABILITY 11 221 1.555e-08 2.342e-07
310 SEGMENTATION 8 89 1.609e-08 2.408e-07
311 EPITHELIAL CELL PROLIFERATION 8 89 1.609e-08 2.408e-07
312 REGULATION OF PHOSPHATASE ACTIVITY 9 128 1.725e-08 2.572e-07
313 AXIS SPECIFICATION 8 90 1.759e-08 2.599e-07
314 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 5 17 1.753e-08 2.599e-07
315 ENDOTHELIUM DEVELOPMENT 8 90 1.759e-08 2.599e-07
316 VASCULOGENESIS 7 59 1.867e-08 2.749e-07
317 DORSAL VENTRAL PATTERN FORMATION 8 91 1.921e-08 2.819e-07
318 CELLULAR RESPONSE TO ACID CHEMICAL 10 175 1.966e-08 2.876e-07
319 EMBRYONIC DIGIT MORPHOGENESIS 7 61 2.368e-08 3.443e-07
320 POSITIVE REGULATION OF STEM CELL PROLIFERATION 7 61 2.368e-08 3.443e-07
321 NOTOCHORD DEVELOPMENT 5 18 2.417e-08 3.504e-07
322 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 6 36 2.459e-08 3.542e-07
323 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 6 36 2.459e-08 3.542e-07
324 NEURAL TUBE FORMATION 8 94 2.485e-08 3.568e-07
325 PROTEIN COMPLEX SUBUNIT ORGANIZATION 26 1527 2.521e-08 3.61e-07
326 REGULATION OF VASCULATURE DEVELOPMENT 11 233 2.682e-08 3.828e-07
327 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 95 2.702e-08 3.845e-07
328 FOREBRAIN DEVELOPMENT 13 357 2.979e-08 4.227e-07
329 CELL MOTILITY 19 835 3.261e-08 4.598e-07
330 LOCALIZATION OF CELL 19 835 3.261e-08 4.598e-07
331 IMMUNE SYSTEM DEVELOPMENT 16 582 3.495e-08 4.913e-07
332 RESPONSE TO ALCOHOL 13 362 3.508e-08 4.916e-07
333 TRACHEA DEVELOPMENT 5 20 4.339e-08 6.062e-07
334 MAMMARY GLAND MORPHOGENESIS 6 40 4.768e-08 6.642e-07
335 CARDIAC CHAMBER MORPHOGENESIS 8 104 5.516e-08 7.617e-07
336 EAR DEVELOPMENT 10 195 5.486e-08 7.617e-07
337 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 8 104 5.516e-08 7.617e-07
338 RESPONSE TO EXTERNAL STIMULUS 28 1821 5.648e-08 7.775e-07
339 NEGATIVE REGULATION OF ORGAN GROWTH 5 21 5.672e-08 7.785e-07
340 NEURON DEVELOPMENT 17 687 5.744e-08 7.861e-07
341 REGULATION OF CELL CELL ADHESION 13 380 6.184e-08 8.438e-07
342 NEURAL PRECURSOR CELL PROLIFERATION 7 70 6.269e-08 8.505e-07
343 REGULATION OF MEMBRANE PERMEABILITY 7 70 6.269e-08 8.505e-07
344 REGULATION OF FAT CELL DIFFERENTIATION 8 106 6.406e-08 8.664e-07
345 PITUITARY GLAND DEVELOPMENT 6 42 6.463e-08 8.695e-07
346 NEURAL TUBE DEVELOPMENT 9 149 6.466e-08 8.695e-07
347 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 10 199 6.642e-08 8.906e-07
348 LEUKOCYTE CELL CELL ADHESION 11 255 6.745e-08 9.018e-07
349 SOMATIC STEM CELL DIVISION 5 22 7.311e-08 9.747e-07
350 BETA CATENIN TCF COMPLEX ASSEMBLY 6 43 7.48e-08 9.945e-07
351 CELL CYCLE ARREST 9 154 8.593e-08 1.139e-06
352 TAXIS 14 464 8.758e-08 1.158e-06
353 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 18 799 9.177e-08 1.21e-06
354 REGULATION OF METANEPHROS DEVELOPMENT 5 23 9.304e-08 1.223e-06
355 RESPONSE TO HORMONE 19 893 9.374e-08 1.229e-06
356 NEURON PROJECTION DEVELOPMENT 15 545 9.639e-08 1.256e-06
357 POSITIVE REGULATION OF MAP KINASE ACTIVITY 10 207 9.615e-08 1.256e-06
358 LUNG MORPHOGENESIS 6 45 9.913e-08 1.288e-06
359 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 7 75 1.017e-07 1.318e-06
360 OVULATION CYCLE 8 113 1.056e-07 1.365e-06
361 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 6 46 1.135e-07 1.463e-06
362 POSITIVE REGULATION OF CELL CYCLE 12 332 1.141e-07 1.467e-06
363 NEURON PROJECTION MORPHOGENESIS 13 402 1.187e-07 1.522e-06
364 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 8 115 1.21e-07 1.547e-06
365 DIENCEPHALON DEVELOPMENT 7 77 1.222e-07 1.553e-06
366 REGULATION OF BMP SIGNALING PATHWAY 7 77 1.222e-07 1.553e-06
367 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 13 404 1.257e-07 1.594e-06
368 REGULATION OF CELL CYCLE PROCESS 15 558 1.307e-07 1.653e-06
369 SOMITE DEVELOPMENT 7 78 1.337e-07 1.686e-06
370 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 8 117 1.384e-07 1.736e-06
371 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 8 117 1.384e-07 1.736e-06
372 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 10 216 1.431e-07 1.79e-06
373 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 6 48 1.475e-07 1.826e-06
374 RESPONSE TO WOUNDING 15 563 1.467e-07 1.826e-06
375 ANTERIOR POSTERIOR AXIS SPECIFICATION 6 48 1.475e-07 1.826e-06
376 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 6 48 1.475e-07 1.826e-06
377 LYMPHOCYTE ACTIVATION 12 342 1.573e-07 1.941e-06
378 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 8 119 1.578e-07 1.943e-06
379 LEUKOCYTE ACTIVATION 13 414 1.665e-07 2.045e-06
380 METANEPHROS DEVELOPMENT 7 81 1.738e-07 2.123e-06
381 REGULATION OF JUN KINASE ACTIVITY 7 81 1.738e-07 2.123e-06
382 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 8 121 1.796e-07 2.188e-06
383 POSITIVE REGULATION OF TRANSPORT 19 936 1.943e-07 2.361e-06
384 RESPONSE TO STEROID HORMONE 14 497 2.027e-07 2.456e-06
385 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 27 2.197e-07 2.648e-06
386 AXIS ELONGATION 5 27 2.197e-07 2.648e-06
387 REGULATION OF CYTOSKELETON ORGANIZATION 14 502 2.288e-07 2.751e-06
388 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 8 126 2.456e-07 2.945e-06
389 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 4 12 2.94e-07 3.498e-06
390 TRACHEA MORPHOGENESIS 4 12 2.94e-07 3.498e-06
391 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 4 12 2.94e-07 3.498e-06
392 VENTRICULAR SEPTUM DEVELOPMENT 6 54 3.03e-07 3.597e-06
393 OVULATION CYCLE PROCESS 7 88 3.083e-07 3.65e-06
394 CRANIAL SKELETAL SYSTEM DEVELOPMENT 6 55 3.387e-07 4e-06
395 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 11 303 3.816e-07 4.495e-06
396 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 8 135 4.172e-07 4.903e-06
397 MITOCHONDRIAL MEMBRANE ORGANIZATION 7 92 4.185e-07 4.905e-06
398 POSITIVE REGULATION OF NEURON DIFFERENTIATION 11 306 4.207e-07 4.919e-06
399 MESENCHYMAL CELL PROLIFERATION 4 13 4.23e-07 4.933e-06
400 EPITHELIAL CELL DEVELOPMENT 9 186 4.29e-07 4.99e-06
401 RESPONSE TO OXYGEN LEVELS 11 311 4.94e-07 5.732e-06
402 REGULATION OF ACTIN FILAMENT BASED PROCESS 11 312 5.099e-07 5.902e-06
403 REGULATION OF PROTEOLYSIS 16 711 5.272e-07 6.087e-06
404 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 9 191 5.363e-07 6.171e-06
405 ENDOCARDIAL CUSHION DEVELOPMENT 5 32 5.371e-07 6.171e-06
406 NEGATIVE REGULATION OF KINASE ACTIVITY 10 250 5.518e-07 6.324e-06
407 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 4 14 5.899e-07 6.727e-06
408 EMBRYONIC SKELETAL JOINT DEVELOPMENT 4 14 5.899e-07 6.727e-06
409 EPIDERMAL CELL DIFFERENTIATION 8 142 6.138e-07 6.983e-06
410 EMBRYONIC AXIS SPECIFICATION 5 33 6.305e-07 7.138e-06
411 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 5 33 6.305e-07 7.138e-06
412 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 8 143 6.475e-07 7.313e-06
413 CELL CYCLE PHASE TRANSITION 10 255 6.612e-07 7.449e-06
414 REGULATION OF MITOTIC CELL CYCLE 13 468 6.703e-07 7.534e-06
415 SOMITOGENESIS 6 62 6.981e-07 7.827e-06
416 WOUND HEALING 13 470 7.032e-07 7.866e-06
417 ORGAN FORMATION 5 34 7.363e-07 8.215e-06
418 RESPONSE TO ESTRADIOL 8 146 7.582e-07 8.441e-06
419 POSITIVE REGULATION OF JUN KINASE ACTIVITY 6 63 7.685e-07 8.534e-06
420 REGULATION OF CELL PROJECTION ORGANIZATION 14 558 8.133e-07 9.01e-06
421 MALE SEX DIFFERENTIATION 8 148 8.407e-07 9.292e-06
422 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 7 102 8.466e-07 9.335e-06
423 AGING 10 264 9.065e-07 9.948e-06
424 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 7 103 9.046e-07 9.948e-06
425 NEURON PROJECTION GUIDANCE 9 205 9.692e-07 1.061e-05
426 NEURON FATE COMMITMENT 6 67 1.11e-06 1.213e-05
427 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 9 209 1.138e-06 1.236e-05
428 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 5 37 1.14e-06 1.236e-05
429 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 5 37 1.14e-06 1.236e-05
430 REGULATION OF CELL DIVISION 10 272 1.188e-06 1.286e-05
431 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 6 68 1.213e-06 1.31e-05
432 BONE DEVELOPMENT 8 156 1.252e-06 1.348e-05
433 BRANCH ELONGATION OF AN EPITHELIUM 4 17 1.386e-06 1.483e-05
434 ESTABLISHMENT OF TISSUE POLARITY 4 17 1.386e-06 1.483e-05
435 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 17 1.386e-06 1.483e-05
436 ACTIVATION OF PROTEIN KINASE ACTIVITY 10 279 1.494e-06 1.595e-05
437 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 7 111 1.501e-06 1.598e-05
438 SKIN EPIDERMIS DEVELOPMENT 6 71 1.568e-06 1.666e-05
439 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 11 351 1.616e-06 1.713e-05
440 ENDOTHELIAL CELL DIFFERENTIATION 6 72 1.704e-06 1.797e-05
441 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 5 40 1.7e-06 1.797e-05
442 KIDNEY MESENCHYME DEVELOPMENT 4 18 1.775e-06 1.869e-05
443 POSITIVE REGULATION OF PROTEIN BINDING 6 73 1.849e-06 1.937e-05
444 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 6 73 1.849e-06 1.937e-05
445 MUSCLE STRUCTURE DEVELOPMENT 12 432 1.862e-06 1.946e-05
446 LUNG ALVEOLUS DEVELOPMENT 5 41 1.928e-06 2.007e-05
447 RECEPTOR CLUSTERING 5 41 1.928e-06 2.007e-05
448 REGULATION OF EPITHELIAL CELL MIGRATION 8 166 1.997e-06 2.074e-05
449 FEMALE SEX DIFFERENTIATION 7 116 2.018e-06 2.091e-05
450 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 8 167 2.088e-06 2.159e-05
451 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 12 437 2.097e-06 2.164e-05
452 EPITHELIAL CELL MORPHOGENESIS 5 42 2.18e-06 2.244e-05
453 CELL CELL ADHESION 14 608 2.23e-06 2.29e-05
454 LEUKOCYTE DIFFERENTIATION 10 292 2.249e-06 2.305e-05
455 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 9 228 2.336e-06 2.389e-05
456 MEMBRANE ORGANIZATION 17 899 2.453e-06 2.503e-05
457 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 6 77 2.533e-06 2.579e-05
458 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 7 121 2.677e-06 2.72e-05
459 TONGUE DEVELOPMENT 4 20 2.789e-06 2.821e-05
460 DORSAL VENTRAL AXIS SPECIFICATION 4 20 2.789e-06 2.821e-05
461 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 7 122 2.828e-06 2.855e-05
462 BONE MORPHOGENESIS 6 79 2.946e-06 2.967e-05
463 THYMOCYTE AGGREGATION 5 45 3.094e-06 3.096e-05
464 T CELL DIFFERENTIATION IN THYMUS 5 45 3.094e-06 3.096e-05
465 ENDOCHONDRAL BONE MORPHOGENESIS 5 45 3.094e-06 3.096e-05
466 POSITIVE REGULATION OF CELL ADHESION 11 376 3.138e-06 3.134e-05
467 POSITIVE REGULATION OF GROWTH 9 238 3.32e-06 3.308e-05
468 CELL AGGREGATION 4 21 3.432e-06 3.398e-05
469 COCHLEA MORPHOGENESIS 4 21 3.432e-06 3.398e-05
470 CARTILAGE CONDENSATION 4 21 3.432e-06 3.398e-05
471 CELL PART MORPHOGENESIS 14 633 3.556e-06 3.513e-05
472 POSITIVE REGULATION OF BINDING 7 127 3.696e-06 3.644e-05
473 BIOLOGICAL ADHESION 18 1032 3.721e-06 3.66e-05
474 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 7 128 3.894e-06 3.823e-05
475 HAIR CYCLE 6 83 3.935e-06 3.847e-05
476 MOLTING CYCLE 6 83 3.935e-06 3.847e-05
477 ENDOCARDIAL CUSHION MORPHOGENESIS 4 22 4.179e-06 4.068e-05
478 ACTIVIN RECEPTOR SIGNALING PATHWAY 4 22 4.179e-06 4.068e-05
479 PROTEIN STABILIZATION 7 131 4.541e-06 4.411e-05
480 REGULATION OF CELL GROWTH 11 391 4.56e-06 4.42e-05
481 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 23 5.039e-06 4.864e-05
482 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 4 23 5.039e-06 4.864e-05
483 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 5 51 5.807e-06 5.593e-05
484 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 7 136 5.818e-06 5.593e-05
485 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 4 24 6.023e-06 5.767e-05
486 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 4 24 6.023e-06 5.767e-05
487 REGULATION OF GLIOGENESIS 6 90 6.309e-06 6.028e-05
488 CELL CYCLE G2 M PHASE TRANSITION 7 138 6.406e-06 6.108e-05
489 REGULATION OF NEURON PROJECTION DEVELOPMENT 11 408 6.826e-06 6.495e-05
490 CARDIAC MUSCLE TISSUE DEVELOPMENT 7 140 7.043e-06 6.674e-05
491 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 53 7.038e-06 6.674e-05
492 FOREBRAIN REGIONALIZATION 4 25 7.143e-06 6.741e-05
493 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 4 25 7.143e-06 6.741e-05
494 INNER EAR MORPHOGENESIS 6 92 7.167e-06 6.751e-05
495 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 8 200 7.932e-06 7.456e-05
496 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 14 684 8.614e-06 8.081e-05
497 SYNAPSE ORGANIZATION 7 145 8.868e-06 8.302e-05
498 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 6 97 9.733e-06 9.094e-05
499 RESPONSE TO LITHIUM ION 4 27 9.833e-06 9.169e-05
500 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 6 98 1.033e-05 9.59e-05
501 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 6 98 1.033e-05 9.59e-05
502 MUSCLE TISSUE DEVELOPMENT 9 275 1.067e-05 9.894e-05
503 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 6 99 1.095e-05 0.0001009
504 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 6 99 1.095e-05 0.0001009
505 LYMPHOCYTE DIFFERENTIATION 8 209 1.094e-05 0.0001009
506 CELL PROJECTION ORGANIZATION 16 902 1.123e-05 0.0001032
507 GASTRULATION WITH MOUTH FORMING SECOND 4 28 1.143e-05 0.0001039
508 CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 4 28 1.143e-05 0.0001039
509 MORPHOGENESIS OF A POLARIZED EPITHELIUM 4 28 1.143e-05 0.0001039
510 DOPAMINERGIC NEURON DIFFERENTIATION 4 28 1.143e-05 0.0001039
511 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 1.143e-05 0.0001039
512 METANEPHROS MORPHOGENESIS 4 28 1.143e-05 0.0001039
513 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 100 1.16e-05 0.0001052
514 REGULATION OF GLIAL CELL DIFFERENTIATION 5 59 1.199e-05 0.0001085
515 KERATINOCYTE DIFFERENTIATION 6 101 1.228e-05 0.000111
516 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 213 1.255e-05 0.0001132
517 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 29 1.32e-05 0.000118
518 AMEBOIDAL TYPE CELL MIGRATION 7 154 1.314e-05 0.000118
519 PROTEIN COMPLEX BIOGENESIS 18 1132 1.324e-05 0.000118
520 EMBRYONIC HINDLIMB MORPHOGENESIS 4 29 1.32e-05 0.000118
521 REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 4 29 1.32e-05 0.000118
522 PROTEIN COMPLEX ASSEMBLY 18 1132 1.324e-05 0.000118
523 REGULATION OF MITOCHONDRION ORGANIZATION 8 218 1.485e-05 0.0001321
524 HORMONE MEDIATED SIGNALING PATHWAY 7 158 1.552e-05 0.0001378
525 CARDIAC VENTRICLE DEVELOPMENT 6 106 1.62e-05 0.0001436
526 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 14 724 1.629e-05 0.0001441
527 NEGATIVE REGULATION OF CELL ADHESION 8 223 1.749e-05 0.0001544
528 REGENERATION 7 161 1.754e-05 0.0001545
529 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 4 32 1.976e-05 0.0001735
530 EMBRYONIC FORELIMB MORPHOGENESIS 4 32 1.976e-05 0.0001735
531 REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH 3 11 2.003e-05 0.0001755
532 PROTEIN LOCALIZATION TO MEMBRANE 10 376 2.059e-05 0.0001801
533 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 5 66 2.081e-05 0.0001813
534 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 5 66 2.081e-05 0.0001813
535 EAR MORPHOGENESIS 6 112 2.217e-05 0.0001928
536 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 5 67 2.24e-05 0.0001937
537 REGULATION OF T CELL APOPTOTIC PROCESS 4 33 2.24e-05 0.0001937
538 EMBRYONIC EYE MORPHOGENESIS 4 33 2.24e-05 0.0001937
539 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 8 232 2.324e-05 0.0002006
540 REGULATION OF ENDOTHELIAL CELL MIGRATION 6 114 2.451e-05 0.0002112
541 NEGATIVE REGULATION OF CELL GROWTH 7 170 2.491e-05 0.0002142
542 LUNG EPITHELIUM DEVELOPMENT 4 34 2.529e-05 0.0002167
543 PROTEIN DESTABILIZATION 4 34 2.529e-05 0.0002167
544 NEGATIVE REGULATION OF OSSIFICATION 5 69 2.586e-05 0.0002207
545 SYNAPSE ASSEMBLY 5 69 2.586e-05 0.0002207
546 RESPONSE TO NITROGEN COMPOUND 15 859 2.613e-05 0.0002226
547 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH 3 12 2.661e-05 0.0002247
548 ANATOMICAL STRUCTURE REGRESSION 3 12 2.661e-05 0.0002247
549 REGULATION OF THYMOCYTE APOPTOTIC PROCESS 3 12 2.661e-05 0.0002247
550 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 3 12 2.661e-05 0.0002247
551 NEGATIVE REGULATION OF HEART GROWTH 3 12 2.661e-05 0.0002247
552 MUSCLE ORGAN MORPHOGENESIS 5 70 2.773e-05 0.0002338
553 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 4 35 2.844e-05 0.0002393
554 REGULATION OF PEPTIDASE ACTIVITY 10 392 2.937e-05 0.0002466
555 ENDODERM DEVELOPMENT 5 71 2.972e-05 0.0002487
556 CELL FATE SPECIFICATION 5 71 2.972e-05 0.0002487
557 CELLULAR RESPONSE TO STRESS 21 1565 2.982e-05 0.0002491
558 GLIOGENESIS 7 175 3e-05 0.0002493
559 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 7 175 3e-05 0.0002493
560 REGULATION OF PROTEIN CATABOLIC PROCESS 10 393 3.001e-05 0.0002493
561 MITOTIC CELL CYCLE 14 766 3.036e-05 0.0002518
562 MULTICELLULAR ORGANISM REPRODUCTION 14 768 3.124e-05 0.0002587
563 HEAD MORPHOGENESIS 4 36 3.187e-05 0.0002634
564 MITOCHONDRIAL TRANSPORT 7 177 3.226e-05 0.0002662
565 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 10 397 3.27e-05 0.0002693
566 PANCREAS DEVELOPMENT 5 73 3.401e-05 0.0002791
567 EMBRYONIC HEART TUBE DEVELOPMENT 5 73 3.401e-05 0.0002791
568 NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 3 13 3.446e-05 0.0002813
569 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 3 13 3.446e-05 0.0002813
570 GDP METABOLIC PROCESS 3 13 3.446e-05 0.0002813
571 HINDLIMB MORPHOGENESIS 4 37 3.56e-05 0.0002901
572 POSITIVE REGULATION OF CELL CYCLE PROCESS 8 247 3.633e-05 0.0002955
573 T CELL DIFFERENTIATION 6 123 3.766e-05 0.0003058
574 MACROMOLECULAR COMPLEX DISASSEMBLY 7 182 3.854e-05 0.0003124
575 ARTERY DEVELOPMENT 5 75 3.877e-05 0.0003137
576 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 38 3.963e-05 0.0003201
577 RENAL VESICLE DEVELOPMENT 3 14 4.37e-05 0.0003494
578 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 3 14 4.37e-05 0.0003494
579 CELL MIGRATION INVOLVED IN GASTRULATION 3 14 4.37e-05 0.0003494
580 METANEPHRIC MESENCHYME DEVELOPMENT 3 14 4.37e-05 0.0003494
581 CONVERGENT EXTENSION 3 14 4.37e-05 0.0003494
582 ADENOHYPOPHYSIS DEVELOPMENT 3 14 4.37e-05 0.0003494
583 COCHLEA DEVELOPMENT 4 39 4.399e-05 0.0003505
584 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 4 39 4.399e-05 0.0003505
585 FORELIMB MORPHOGENESIS 4 40 4.869e-05 0.0003873
586 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 6 129 4.92e-05 0.00039
587 REGULATION OF REPRODUCTIVE PROCESS 6 129 4.92e-05 0.00039
588 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 258 4.943e-05 0.0003912
589 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 5 80 5.293e-05 0.0004182
590 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 4 41 5.374e-05 0.0004231
591 PROSTATE GLAND DEVELOPMENT 4 41 5.374e-05 0.0004231
592 MESENCHYMAL TO EPITHELIAL TRANSITION 3 15 5.442e-05 0.0004242
593 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 3 15 5.442e-05 0.0004242
594 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 3 15 5.442e-05 0.0004242
595 REGULATION OF NEURON APOPTOTIC PROCESS 7 192 5.412e-05 0.0004242
596 REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 3 15 5.442e-05 0.0004242
597 POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS 3 15 5.442e-05 0.0004242
598 POSITIVE REGULATION OF CELL DIVISION 6 132 5.594e-05 0.0004346
599 MAINTENANCE OF CELL NUMBER 6 132 5.594e-05 0.0004346
600 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 8 263 5.658e-05 0.000438
601 NEGATIVE REGULATION OF LOCOMOTION 8 263 5.658e-05 0.000438
602 POSTTRANSCRIPTIONAL GENE SILENCING 4 42 5.917e-05 0.0004566
603 REGULATION OF HEART GROWTH 4 42 5.917e-05 0.0004566
604 EMBRYONIC PLACENTA DEVELOPMENT 5 83 6.317e-05 0.0004867
605 MACROMOLECULAR COMPLEX ASSEMBLY 19 1398 6.445e-05 0.0004956
606 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 4 43 6.499e-05 0.0004982
607 MORPHOGENESIS OF AN EPITHELIAL SHEET 4 43 6.499e-05 0.0004982
608 RESPONSE TO DRUG 10 431 6.515e-05 0.0004986
609 GLIAL CELL DIFFERENTIATION 6 136 6.607e-05 0.0005048
610 PROTEIN LOCALIZATION TO SYNAPSE 3 16 6.674e-05 0.0005082
611 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 3 16 6.674e-05 0.0005082
612 HINDBRAIN DEVELOPMENT 6 137 6.881e-05 0.0005232
613 LABYRINTHINE LAYER DEVELOPMENT 4 44 7.121e-05 0.0005397
614 BODY MORPHOGENESIS 4 44 7.121e-05 0.0005397
615 PLACENTA DEVELOPMENT 6 138 7.165e-05 0.0005421
616 ENDOTHELIAL CELL DEVELOPMENT 4 45 7.786e-05 0.0005871
617 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 4 45 7.786e-05 0.0005871
618 TISSUE REMODELING 5 87 7.912e-05 0.0005957
619 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 3 17 8.074e-05 0.000604
620 CELLULAR RESPONSE TO LITHIUM ION 3 17 8.074e-05 0.000604
621 NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 17 8.074e-05 0.000604
622 REGULATION OF STEM CELL POPULATION MAINTENANCE 3 17 8.074e-05 0.000604
623 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 4 46 8.494e-05 0.0006344
624 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 8 282 9.206e-05 0.0006865
625 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 4 47 9.249e-05 0.0006874
626 POSITIVE REGULATION OF GLIOGENESIS 4 47 9.249e-05 0.0006874
627 POSITIVE REGULATION OF PROTEOLYSIS 9 363 9.312e-05 0.000691
628 NEGATIVE REGULATION OF MAPK CASCADE 6 145 9.422e-05 0.0006981
629 PERICARDIUM DEVELOPMENT 3 18 9.653e-05 0.0007118
630 OSTEOBLAST DEVELOPMENT 3 18 9.653e-05 0.0007118
631 UTERUS DEVELOPMENT 3 18 9.653e-05 0.0007118
632 POSITIVE REGULATION OF CELL GROWTH 6 148 0.0001055 0.0007766
633 REGULATION OF STEROID BIOSYNTHETIC PROCESS 4 49 0.000109 0.0008013
634 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 3 19 0.0001142 0.0008382
635 FACE DEVELOPMENT 4 50 0.000118 0.0008649
636 ARTERY MORPHOGENESIS 4 51 0.0001276 0.0009335
637 REGULATION OF CYTOKINE PRODUCTION 11 563 0.0001285 0.0009386
638 POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 3 20 0.0001339 0.0009733
639 GMP METABOLIC PROCESS 3 20 0.0001339 0.0009733
640 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 3 20 0.0001339 0.0009733
641 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 6 156 0.0001408 0.00102
642 PROTEIN LOCALIZATION TO NUCLEUS 6 156 0.0001408 0.00102
643 CHONDROCYTE DEVELOPMENT 3 21 0.0001556 0.001123
644 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 3 21 0.0001556 0.001123
645 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 3 21 0.0001556 0.001123
646 TELENCEPHALON DEVELOPMENT 7 228 0.0001583 0.00114
647 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 4 54 0.0001596 0.001144
648 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 4 54 0.0001596 0.001144
649 CARDIAC MUSCLE TISSUE MORPHOGENESIS 4 54 0.0001596 0.001144
650 REGULATION OF GENE EXPRESSION EPIGENETIC 7 229 0.0001626 0.001164
651 SINGLE ORGANISM CELLULAR LOCALIZATION 14 898 0.0001655 0.001183
652 REGULATION OF LEUKOCYTE DIFFERENTIATION 7 232 0.0001761 0.001257
653 REGULATION OF NUCLEAR DIVISION 6 163 0.0001788 0.001274
654 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 0.0001795 0.001277
655 POSITIVE REGULATION OF PROTEIN IMPORT 5 104 0.000184 0.001305
656 OUTFLOW TRACT MORPHOGENESIS 4 56 0.0001839 0.001305
657 CELL SUBSTRATE ADHESION 6 164 0.0001849 0.001309
658 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 4 57 0.0001971 0.001391
659 ENDOTHELIAL CELL MIGRATION 4 57 0.0001971 0.001391
660 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 6 166 0.0001975 0.001392
661 MUSCLE CELL DIFFERENTIATION 7 237 0.0002007 0.001413
662 FAT CELL DIFFERENTIATION 5 106 0.0002012 0.001414
663 ESTABLISHMENT OF EPITHELIAL CELL POLARITY 3 23 0.0002057 0.001441
664 SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 3 23 0.0002057 0.001441
665 REGULATION OF IMMUNE SYSTEM PROCESS 18 1403 0.0002126 0.001488
666 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 4 59 0.0002253 0.001574
667 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 3 24 0.0002342 0.001627
668 REGULATION OF ODONTOGENESIS 3 24 0.0002342 0.001627
669 ENDOTHELIAL CELL PROLIFERATION 3 24 0.0002342 0.001627
670 POSITIVE REGULATION OF CELL CELL ADHESION 7 243 0.0002338 0.001627
671 NEGATIVE REGULATION OF CELL DIVISION 4 60 0.0002405 0.001663
672 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 4 60 0.0002405 0.001663
673 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 4 60 0.0002405 0.001663
674 REGULATION OF CELL SUBSTRATE ADHESION 6 173 0.0002468 0.001704
675 OVARIAN FOLLICLE DEVELOPMENT 4 61 0.0002563 0.001767
676 LENS FIBER CELL DIFFERENTIATION 3 25 0.0002652 0.001812
677 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 3 25 0.0002652 0.001812
678 LUNG CELL DIFFERENTIATION 3 25 0.0002652 0.001812
679 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 25 0.0002652 0.001812
680 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 25 0.0002652 0.001812
681 EPITHELIAL CELL APOPTOTIC PROCESS 3 25 0.0002652 0.001812
682 REGULATION OF SMOOTHENED SIGNALING PATHWAY 4 62 0.000273 0.001862
683 NEUROEPITHELIAL CELL DIFFERENTIATION 4 63 0.0002903 0.001978
684 REGULATION OF NEURON DEATH 7 252 0.0002916 0.001984
685 DEVELOPMENTAL PROGRAMMED CELL DEATH 3 26 0.0002987 0.00202
686 NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 3 26 0.0002987 0.00202
687 REGULATION OF HORMONE METABOLIC PROCESS 3 26 0.0002987 0.00202
688 REGULATION OF P38MAPK CASCADE 3 26 0.0002987 0.00202
689 REGULATION OF CHEMOTAXIS 6 180 0.0003055 0.002063
690 REGULATION OF CELLULAR COMPONENT SIZE 8 337 0.0003103 0.002092
691 IMMUNE SYSTEM PROCESS 22 1984 0.0003109 0.002094
692 REGULATION OF CATABOLIC PROCESS 12 731 0.0003153 0.00212
693 REGULATION OF DNA METABOLIC PROCESS 8 340 0.0003292 0.00221
694 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 3 27 0.0003348 0.002241
695 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 3 27 0.0003348 0.002241
696 SOMATIC STEM CELL POPULATION MAINTENANCE 4 66 0.0003473 0.002322
697 POSITIVE REGULATION OF DNA METABOLIC PROCESS 6 185 0.0003536 0.002361
698 POSITIVE REGULATION OF NEURON DEATH 4 67 0.0003679 0.002452
699 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 3 28 0.0003736 0.00248
700 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 3 28 0.0003736 0.00248
701 REGULATION OF NEUROBLAST PROLIFERATION 3 28 0.0003736 0.00248
702 CELLULAR RESPONSE TO ABIOTIC STIMULUS 7 263 0.0003773 0.002501
703 CELLULAR RESPONSE TO EXTERNAL STIMULUS 7 264 0.000386 0.002552
704 LOCALIZATION WITHIN MEMBRANE 5 122 0.0003862 0.002552
705 REGULATION OF CELL JUNCTION ASSEMBLY 4 68 0.0003894 0.00257
706 RESPONSE TO EXTRACELLULAR STIMULUS 9 441 0.0003955 0.002607
707 PROTEIN DEPHOSPHORYLATION 6 190 0.0004076 0.002682
708 EPIDERMIS MORPHOGENESIS 3 29 0.0004152 0.002725
709 NEUROBLAST PROLIFERATION 3 29 0.0004152 0.002725
710 STEROID HORMONE MEDIATED SIGNALING PATHWAY 5 125 0.0004318 0.00283
711 PROTEASOMAL PROTEIN CATABOLIC PROCESS 7 271 0.0004515 0.002955
712 CELL CYCLE CHECKPOINT 6 194 0.0004552 0.002975
713 SMOOTH MUSCLE CELL DIFFERENTIATION 3 30 0.0004596 0.002991
714 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING 4 71 0.0004592 0.002991
715 ESTABLISHMENT OF ENDOTHELIAL BARRIER 3 30 0.0004596 0.002991
716 CELLULAR RESPONSE TO HORMONE STIMULUS 10 552 0.0004789 0.003112
717 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 7 274 0.0004821 0.003129
718 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 4 73 0.0005105 0.003308
719 NEGATIVE REGULATION OF TRANSPORT 9 458 0.0005197 0.003363
720 NEGATIVE REGULATION OF BINDING 5 131 0.000535 0.003457
721 REGULATION OF STEROID METABOLIC PROCESS 4 74 0.0005376 0.003469
722 NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 3 32 0.0005574 0.003577
723 SALIVARY GLAND DEVELOPMENT 3 32 0.0005574 0.003577
724 POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION 3 32 0.0005574 0.003577
725 PATTERNING OF BLOOD VESSELS 3 32 0.0005574 0.003577
726 NEURAL CREST CELL DIFFERENTIATION 4 75 0.0005657 0.003625
727 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 5 133 0.0005732 0.003669
728 REGULATION OF MYELINATION 3 33 0.0006109 0.003899
729 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 3 33 0.0006109 0.003899
730 NEGATIVE REGULATION OF DEPHOSPHORYLATION 4 77 0.000625 0.003984
731 POSITIVE REGULATION OF HYDROLASE ACTIVITY 13 905 0.0006261 0.003985
732 CIRCADIAN RHYTHM 5 137 0.0006557 0.004168
733 HEART VALVE DEVELOPMENT 3 34 0.0006676 0.004226
734 NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION 3 34 0.0006676 0.004226
735 BRAIN MORPHOGENESIS 3 34 0.0006676 0.004226
736 NEGATIVE REGULATION OF CELL CELL ADHESION 5 138 0.0006777 0.004284
737 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 4 79 0.0006886 0.004341
738 NEGATIVE REGULATION OF PROTEIN BINDING 4 79 0.0006886 0.004341
739 MITOTIC CELL CYCLE CHECKPOINT 5 139 0.0007002 0.004409
740 BONE REMODELING 3 35 0.0007275 0.004574
741 REGULATION OF FIBROBLAST PROLIFERATION 4 81 0.0007566 0.004751
742 NEGATIVE REGULATION OF CELL CYCLE PROCESS 6 214 0.000762 0.004779
743 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 3 36 0.0007907 0.004952
744 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 4 82 0.0007923 0.004955
745 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 5 144 0.0008212 0.005129
746 RESPONSE TO IONIZING RADIATION 5 145 0.0008472 0.005284
747 NEGATIVE REGULATION OF GLIOGENESIS 3 37 0.0008574 0.00534
748 TISSUE MIGRATION 4 84 0.0008674 0.005396
749 POSITIVE REGULATION OF CATABOLIC PROCESS 8 395 0.0008812 0.005474
750 BONE MINERALIZATION 3 38 0.0009275 0.005754
751 PEPTIDYL SERINE MODIFICATION 5 148 0.0009287 0.005754
752 POSITIVE REGULATION OF DNA REPLICATION 4 86 0.0009473 0.005861
753 NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 3 39 0.001001 0.00617
754 REGULATION OF AXON GUIDANCE 3 39 0.001001 0.00617
755 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 3 39 0.001001 0.00617
756 RESPONSE TO PEPTIDE 8 404 0.001018 0.006268
757 CELLULAR RESPONSE TO NITROGEN COMPOUND 9 505 0.001038 0.006382
758 PROTEIN TARGETING 8 406 0.001051 0.006452
759 REGULATION OF HEMOPOIESIS 7 314 0.001073 0.00658
760 POSITIVE REGULATION OF CELL MATRIX ADHESION 3 40 0.001078 0.006584
761 ENDODERMAL CELL DIFFERENTIATION 3 40 0.001078 0.006584
762 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 5 153 0.001078 0.006584
763 REGULATION OF CELL MATRIX ADHESION 4 90 0.001122 0.006845
764 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 3 41 0.001159 0.007041
765 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 3 41 0.001159 0.007041
766 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 3 41 0.001159 0.007041
767 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 3 42 0.001244 0.007526
768 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 3 42 0.001244 0.007526
769 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 3 42 0.001244 0.007526
770 REGULATION OF DNA BINDING 4 93 0.001268 0.007662
771 REGULATION OF DNA BIOSYNTHETIC PROCESS 4 94 0.001319 0.007961
772 ENDOCARDIUM DEVELOPMENT 2 11 0.001348 0.008084
773 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 2 11 0.001348 0.008084
774 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 2 11 0.001348 0.008084
775 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 2 11 0.001348 0.008084
776 ENDOTHELIAL TUBE MORPHOGENESIS 2 11 0.001348 0.008084
777 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 4 95 0.001372 0.008215
778 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 12 867 0.001406 0.008412
779 MYELOID LEUKOCYTE DIFFERENTIATION 4 96 0.001426 0.008507
780 NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 3 44 0.001424 0.008507
781 REGULATION OF MICROTUBULE BASED PROCESS 6 243 0.001466 0.008732
782 EXOCRINE SYSTEM DEVELOPMENT 3 45 0.001521 0.009048
783 ANTERIOR POSTERIOR AXIS SPECIFICATION EMBRYO 2 12 0.001612 0.009485
784 CARTILAGE MORPHOGENESIS 2 12 0.001612 0.009485
785 HEART FORMATION 2 12 0.001612 0.009485
786 MAINTENANCE OF CELL POLARITY 2 12 0.001612 0.009485
787 TRIPARTITE REGIONAL SUBDIVISION 2 12 0.001612 0.009485
788 COLLECTING DUCT DEVELOPMENT 2 12 0.001612 0.009485
789 POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 2 12 0.001612 0.009485
790 EMBRYONIC CAMERA TYPE EYE FORMATION 2 12 0.001612 0.009485
791 LENS FIBER CELL DEVELOPMENT 2 12 0.001612 0.009485
792 NEGATIVE REGULATION OF DNA BINDING 3 46 0.001621 0.009487
793 GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS 3 46 0.001621 0.009487
794 PEPTIDYL THREONINE MODIFICATION 3 46 0.001621 0.009487
795 NEGATIVE REGULATION OF NUCLEAR DIVISION 3 46 0.001621 0.009487
796 REGULATION OF AXONOGENESIS 5 168 0.00163 0.009531
NumGOOverlapSizeP ValueAdj. P Value
1 FRIZZLED BINDING 15 36 6.105e-26 5.671e-23
2 RECEPTOR BINDING 40 1476 8.647e-20 4.016e-17
3 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 12 50 1.452e-17 4.496e-15
4 BETA CATENIN BINDING 13 84 2.913e-16 6.765e-14
5 WNT ACTIVATED RECEPTOR ACTIVITY 9 22 6.988e-16 1.298e-13
6 ENZYME BINDING 38 1737 1.267e-15 1.961e-13
7 KINASE BINDING 23 606 2.768e-14 3.214e-12
8 WNT PROTEIN BINDING 9 31 2.728e-14 3.214e-12
9 SMAD BINDING 10 72 2.829e-12 2.92e-10
10 G PROTEIN COUPLED RECEPTOR BINDING 15 259 3.552e-12 3.3e-10
11 I SMAD BINDING 6 11 6.459e-12 5.455e-10
12 PROTEIN DOMAIN SPECIFIC BINDING 19 624 2.797e-10 2.165e-08
13 GAMMA CATENIN BINDING 5 12 2.289e-09 1.635e-07
14 GROWTH FACTOR ACTIVITY 10 160 8.327e-09 5.31e-07
15 RECEPTOR SERINE THREONINE KINASE BINDING 5 15 8.574e-09 5.31e-07
16 RECEPTOR AGONIST ACTIVITY 5 16 1.242e-08 6.788e-07
17 CYTOKINE RECEPTOR BINDING 12 271 1.228e-08 6.788e-07
18 CYTOKINE ACTIVITY 11 219 1.416e-08 7.306e-07
19 RECEPTOR SIGNALING PROTEIN ACTIVITY 10 172 1.666e-08 8.148e-07
20 SIGNAL TRANSDUCER ACTIVITY 27 1731 7.818e-08 3.631e-06
21 IONOTROPIC GLUTAMATE RECEPTOR BINDING 5 23 9.304e-08 4.116e-06
22 MOLECULAR FUNCTION REGULATOR 23 1353 2.006e-07 8.471e-06
23 PROTEIN DIMERIZATION ACTIVITY 21 1149 2.307e-07 9.319e-06
24 PDZ DOMAIN BINDING 7 90 3.599e-07 1.393e-05
25 RECEPTOR ACTIVATOR ACTIVITY 5 32 5.371e-07 1.996e-05
26 REGULATORY REGION NUCLEIC ACID BINDING 17 818 6.759e-07 2.415e-05
27 UBIQUITIN LIKE PROTEIN LIGASE BINDING 10 264 9.065e-07 3.119e-05
28 GLUTAMATE RECEPTOR BINDING 5 37 1.14e-06 3.781e-05
29 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 4 17 1.386e-06 4.441e-05
30 MACROMOLECULAR COMPLEX BINDING 22 1399 1.447e-06 4.48e-05
31 TRANSCRIPTION FACTOR BINDING 13 524 2.353e-06 7.05e-05
32 RECEPTOR REGULATOR ACTIVITY 5 45 3.094e-06 8.981e-05
33 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 4 21 3.432e-06 9.662e-05
34 PROTEIN HETERODIMERIZATION ACTIVITY 12 468 4.239e-06 0.0001125
35 PROTEIN COMPLEX BINDING 17 935 4.151e-06 0.0001125
36 KINASE ACTIVITY 16 842 4.732e-06 0.0001221
37 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 6 92 7.167e-06 0.00018
38 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 6 104 1.453e-05 0.0003551
39 PROTEIN SERINE THREONINE KINASE ACTIVITY 11 445 1.538e-05 0.0003664
40 CORE PROMOTER PROXIMAL REGION DNA BINDING 10 371 1.836e-05 0.0004263
41 PROTEIN KINASE ACTIVITY 13 640 2.012e-05 0.0004558
42 GUANYLATE KINASE ACTIVITY 3 12 2.661e-05 0.0005885
43 ARMADILLO REPEAT DOMAIN BINDING 3 13 3.446e-05 0.0007445
44 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 16 992 3.592e-05 0.0007583
45 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 9 328 4.277e-05 0.0008829
46 PROTEIN C TERMINUS BINDING 7 186 4.426e-05 0.0008938
47 TRANSFORMING GROWTH FACTOR BETA BINDING 3 16 6.674e-05 0.001319
48 PHOSPHATASE REGULATOR ACTIVITY 5 87 7.912e-05 0.001531
49 ENZYME REGULATOR ACTIVITY 15 959 9.125e-05 0.00173
50 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 17 1199 9.929e-05 0.001845
51 CYTOKINE BINDING 5 92 0.0001032 0.00188
52 IDENTICAL PROTEIN BINDING 17 1209 0.0001098 0.001962
53 TRANSCRIPTION COREPRESSOR ACTIVITY 7 221 0.0001305 0.002288
54 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 7 226 0.0001499 0.002579
55 PHOSPHATASE BINDING 6 162 0.000173 0.002921
56 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 11 588 0.0001875 0.003111
57 R SMAD BINDING 3 23 0.0002057 0.003353
58 NUCLEOTIDE KINASE ACTIVITY 3 24 0.0002342 0.003752
59 CHROMATIN BINDING 9 435 0.000358 0.005635
60 CELL ADHESION MOLECULE BINDING 6 186 0.000364 0.005635
61 CADHERIN BINDING 3 28 0.0003736 0.00569
62 GROWTH FACTOR BINDING 5 123 0.000401 0.006008
63 DOUBLE STRANDED DNA BINDING 12 764 0.0004686 0.006911
NumGOOverlapSizeP ValueAdj. P Value
1 APICAL JUNCTION COMPLEX 15 128 9.983e-17 2.915e-14
2 WNT SIGNALOSOME 8 11 5.194e-17 2.915e-14
3 CELL JUNCTION 29 1151 2.465e-13 4.798e-11
4 EXTRACELLULAR MATRIX 19 426 3.824e-13 5.582e-11
5 CELL CELL JUNCTION 18 383 7.062e-13 8.248e-11
6 PROTEINACEOUS EXTRACELLULAR MATRIX 15 356 3.166e-10 3.081e-08
7 EXTRACELLULAR SPACE 26 1376 2.939e-09 2.452e-07
8 BETA CATENIN DESTRUCTION COMPLEX 5 14 5.739e-09 4.189e-07
9 TRANSCRIPTION FACTOR COMPLEX 12 298 3.511e-08 2.278e-06
10 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 5 20 4.339e-08 2.534e-06
11 PHOSPHATASE COMPLEX 6 48 1.475e-07 7.833e-06
12 ANCHORING JUNCTION 14 489 1.664e-07 8.098e-06
13 CELL SURFACE 17 757 2.29e-07 1.029e-05
14 PLASMA MEMBRANE PROTEIN COMPLEX 14 510 2.771e-07 1.156e-05
15 CYTOPLASMIC VESICLE PART 15 601 3.382e-07 1.317e-05
16 PLASMA MEMBRANE RECEPTOR COMPLEX 8 175 2.961e-06 0.0001081
17 INTRACELLULAR VESICLE 20 1259 4.094e-06 0.0001407
18 LATERAL PLASMA MEMBRANE 5 50 5.259e-06 0.0001706
19 VESICLE MEMBRANE 12 512 1.051e-05 0.000323
20 ENDOCYTIC VESICLE MEMBRANE 7 152 1.207e-05 0.0003524
21 MEMBRANE REGION 18 1134 1.356e-05 0.0003771
22 MEMBRANE MICRODOMAIN 9 288 1.542e-05 0.0004093
23 MICROTUBULE CYTOSKELETON 17 1068 2.349e-05 0.0005965
24 CELL SUBSTRATE JUNCTION 10 398 3.34e-05 0.0008127
25 RECEPTOR COMPLEX 9 327 4.177e-05 0.0009757
26 ENDOCYTIC VESICLE 8 256 4.679e-05 0.001051
27 MICROTUBULE ORGANIZING CENTER 12 623 7.143e-05 0.001545
28 PROTEIN KINASE COMPLEX 5 90 9.299e-05 0.00194
29 CYTOSKELETON 23 1967 9.96e-05 0.002006
30 GOLGI LUMEN 5 94 0.0001143 0.002225
31 INTERCALATED DISC 4 51 0.0001276 0.002404
32 CELL CELL ADHERENS JUNCTION 4 54 0.0001596 0.002913
33 CELL BODY 10 494 0.0001989 0.003416
34 CYTOPLASMIC MICROTUBULE 4 57 0.0001971 0.003416
35 CELL CORTEX 7 238 0.000206 0.003437
36 PLASMA MEMBRANE REGION 14 929 0.0002347 0.003808
37 CELL PROJECTION PART 14 946 0.0002824 0.004458
38 CELL CELL CONTACT ZONE 4 64 0.0003085 0.004741
39 CHROMATIN 9 441 0.0003955 0.005923
40 SPINDLE POLE 5 126 0.0004478 0.006379
41 SOMATODENDRITIC COMPARTMENT 11 650 0.0004404 0.006379
42 CHROMOSOME 13 880 0.0004816 0.006696
43 EXCITATORY SYNAPSE 6 197 0.0004937 0.006705
44 CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 3 31 0.000507 0.006729
45 MEMBRANE PROTEIN COMPLEX 14 1020 6e-04 0.007787
46 CYTOPLASMIC REGION 7 287 0.0006346 0.007885
47 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 5 136 0.0006343 0.007885
48 NUCLEAR CHROMATIN 7 291 0.0006885 0.008377
49 CATALYTIC COMPLEX 14 1038 0.0007123 0.00849
50 CENTROSOME 9 487 0.0008047 0.009326
51 CYTOSKELETAL PART 17 1436 0.0008145 0.009326
52 DENDRITIC SHAFT 3 37 0.0008574 0.009629
53 NEURON PROJECTION 13 942 0.0009066 0.00999

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04390_Hippo_signaling_pathway 101 154 3.671e-233 6.608e-231
2 hsa04310_Wnt_signaling_pathway 41 151 6.302e-62 5.672e-60
3 hsa04916_Melanogenesis 27 101 4.337e-40 2.602e-38
4 hsa04340_Hedgehog_signaling_pathway 20 56 1.07e-32 4.814e-31
5 hsa04350_TGF.beta_signaling_pathway 21 85 2.158e-30 7.768e-29
6 hsa04520_Adherens_junction 12 73 2e-15 6e-14
7 hsa04110_Cell_cycle 13 128 8.226e-14 2.115e-12
8 hsa04530_Tight_junction 13 133 1.359e-13 3.058e-12
9 hsa04151_PI3K_AKT_signaling_pathway 15 351 2.602e-10 5.204e-09
10 hsa04114_Oocyte_meiosis 9 114 6.216e-09 1.119e-07
11 hsa04144_Endocytosis 10 203 8.007e-08 1.31e-06
12 hsa04115_p53_signaling_pathway 6 69 1.323e-06 1.985e-05
13 hsa04722_Neurotrophin_signaling_pathway 6 127 4.507e-05 0.0006241
14 hsa03015_mRNA_surveillance_pathway 5 83 6.317e-05 0.0008122
15 hsa04510_Focal_adhesion 7 200 7.001e-05 0.0008401
16 hsa04010_MAPK_signaling_pathway 7 268 0.0004224 0.004752
17 hsa04810_Regulation_of_actin_cytoskeleton 6 214 0.000762 0.008069
18 hsa04670_Leukocyte_transendothelial_migration 4 117 0.002936 0.02936
19 hsa04710_Circadian_rhythm_._mammal 2 23 0.005962 0.05648
20 hsa04630_Jak.STAT_signaling_pathway 4 155 0.007922 0.0713
21 hsa04330_Notch_signaling_pathway 2 47 0.02355 0.2019
22 hsa04380_Osteoclast_differentiation 3 128 0.0271 0.2217
23 hsa04910_Insulin_signaling_pathway 3 138 0.03282 0.2569
24 hsa04730_Long.term_depression 2 70 0.04885 0.3663
25 hsa04012_ErbB_signaling_pathway 2 87 0.07165 0.5159
26 hsa04660_T_cell_receptor_signaling_pathway 2 108 0.1035 0.7166
27 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.1558 1
28 hsa04145_Phagosome 2 156 0.1863 1
29 hsa04062_Chemokine_signaling_pathway 2 189 0.2474 1
30 hsa04014_Ras_signaling_pathway 2 236 0.335 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 12 AXIN2 Sponge network -6.205 0.00015 -3.824 0.00033 0.595
2

MAGI2-AS3

 hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p 11 AXIN2 Sponge network -4.563 0 -3.824 0.00033 0.525
3

AC073283.4

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-205-5p;hsa-miR-22-3p;hsa-miR-221-3p;hsa-miR-2355-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-342-3p;hsa-miR-34c-3p;hsa-miR-944 11 AMOT Sponge network -2.801 0.08856 -1.936 0.20701 0.524
4

HAND2-AS1

 hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 12 AXIN2 Sponge network -7.871 0 -3.824 0.00033 0.523
5

RP11-384L8.1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-205-5p;hsa-miR-22-3p;hsa-miR-221-3p;hsa-miR-2355-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-330-3p;hsa-miR-330-5p 10 AMOT Sponge network -1.784 0.21615 -1.936 0.20701 0.501
6

MEG3

 hsa-let-7b-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-944 11 AXIN2 Sponge network -3.613 0.00075 -3.824 0.00033 0.496
7 FRMD6-AS2 hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20b-5p;hsa-miR-29b-2-5p;hsa-miR-301a-3p;hsa-miR-375 10 FRMD6 Sponge network -12.644 0 -1.608 0.08207 0.494
8

MAGI2-AS3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-9-3p;hsa-miR-92a-3p;hsa-miR-93-5p 13 TGFBR2 Sponge network -4.563 0 -2.733 2.0E-5 0.479
9

TRHDE-AS1

 hsa-let-7g-3p;hsa-miR-130a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-27a-5p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-330-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-3928-3p;hsa-miR-484;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-769-3p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-93-3p 25 DLG2 Sponge network -6.205 0.01165 -4.94 0.00023 0.476
10

ADAMTS9-AS1

 hsa-let-7g-3p;hsa-miR-130a-5p;hsa-miR-135b-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-3613-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-769-3p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-93-3p 25 DLG2 Sponge network -8.573 0.00012 -4.94 0.00023 0.474
11

RP11-166D19.1

 hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 15 FZD4 Sponge network -4.209 2.0E-5 -2.839 4.0E-5 0.456
12

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-205-5p;hsa-miR-21-3p;hsa-miR-22-3p;hsa-miR-221-3p;hsa-miR-2355-3p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-944 10 AMOT Sponge network -6.205 0.00015 -1.936 0.20701 0.452
13

MAGI2-AS3

 hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-93-5p 11 LATS2 Sponge network -4.563 0 -1.641 0.00068 0.434
14

RASSF8-AS1

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-590-3p;hsa-miR-944 10 AXIN2 Sponge network -2.562 0.00163 -3.824 0.00033 0.431
15

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-9-5p;hsa-miR-92a-3p 13 TGFBR2 Sponge network -4.209 2.0E-5 -2.733 2.0E-5 0.422
16 RP5-1042I8.7 hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-32-3p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-93-3p 10 DLG2 Sponge network -0.504 0.36806 -4.94 0.00023 0.414
17

RP11-166D19.1

 hsa-let-7g-3p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-3928-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-944 27 DLG2 Sponge network -4.209 2.0E-5 -4.94 0.00023 0.406
18

HAND2-AS1

 hsa-let-7g-3p;hsa-miR-130a-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-93-3p;hsa-miR-944 28 DLG2 Sponge network -7.871 0 -4.94 0.00023 0.395
19 AC005682.5 hsa-miR-106a-5p;hsa-miR-10a-3p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-3065-5p 11 CCND2 Sponge network -2.193 0.07184 -2.811 0.0014 0.394
20

HAND2-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p 12 TGFBR2 Sponge network -7.871 0 -2.733 2.0E-5 0.394
21 RP11-774O3.3 hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3928-3p;hsa-miR-93-3p 16 DLG2 Sponge network -1.989 0.00136 -4.94 0.00023 0.394
22 RP11-999E24.3 hsa-let-7g-3p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-93-3p 15 DLG2 Sponge network -4.893 2.0E-5 -4.94 0.00023 0.393
23 AC003090.1 hsa-miR-130a-5p;hsa-miR-135b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-330-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-582-5p;hsa-miR-590-5p 18 DLG2 Sponge network -7.817 0.00161 -4.94 0.00023 0.391
24

ACTA2-AS1

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-93-3p 10 BMPR2 Sponge network -6.142 0.00223 -1.126 0.00109 0.39
25 RP4-607I7.1 hsa-miR-106a-5p;hsa-miR-141-3p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20b-5p;hsa-miR-29b-2-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-671-5p;hsa-miR-93-5p 12 FRMD6 Sponge network -0.625 0.69827 -1.608 0.08207 0.384
26

RP11-244O19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-93-5p 12 CCND2 Sponge network -1.318 0.0924 -2.811 0.0014 0.383
27

MAGI2-AS3

 hsa-let-7g-3p;hsa-miR-130a-5p;hsa-miR-135b-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-3928-3p;hsa-miR-590-3p;hsa-miR-642a-5p;hsa-miR-769-3p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-93-3p 32 DLG2 Sponge network -4.563 0 -4.94 0.00023 0.382
28

MAGI2-AS3

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 15 FZD4 Sponge network -4.563 0 -2.839 4.0E-5 0.382
29

DNM3OS

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p;hsa-miR-93-5p 12 BMPR2 Sponge network -3.933 0.00059 -1.126 0.00109 0.382
30

ACTA2-AS1

 hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-944 12 AXIN2 Sponge network -6.142 0.00223 -3.824 0.00033 0.379
31

RP11-166D19.1

 hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-96-5p 10 LATS2 Sponge network -4.209 2.0E-5 -1.641 0.00068 0.378
32

ACTA2-AS1

 hsa-let-7g-3p;hsa-miR-130a-3p;hsa-miR-130a-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-628-3p;hsa-miR-769-3p;hsa-miR-93-3p;hsa-miR-944 28 DLG2 Sponge network -6.142 0.00223 -4.94 0.00023 0.377
33

MAGI2-AS3

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 15 BMPR2 Sponge network -4.563 0 -1.126 0.00109 0.376
34 DIO3OS hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-378a-3p 13 CCND2 Sponge network -4.295 0.00689 -2.811 0.0014 0.374
35

MEG3

 hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-629-3p 13 FZD4 Sponge network -3.613 0.00075 -2.839 4.0E-5 0.369
36

TPTEP1

 hsa-let-7a-3p;hsa-let-7f-2-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-3614-5p;hsa-miR-590-3p 10 AXIN2 Sponge network -4.398 5.0E-5 -3.824 0.00033 0.368
37 ZNF667-AS1 hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-3613-5p;hsa-miR-484 15 DLG2 Sponge network -4.019 0.00137 -4.94 0.00023 0.367
38

RP11-554A11.4

 hsa-miR-135b-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-3928-3p 13 DLG2 Sponge network -5.361 2.0E-5 -4.94 0.00023 0.366
39 LINC00899 hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-185-5p;hsa-miR-22-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-484;hsa-miR-769-3p;hsa-miR-93-3p 12 DLG2 Sponge network -1.597 0.00258 -4.94 0.00023 0.366
40

MIR143HG

 hsa-let-7g-3p;hsa-miR-130a-5p;hsa-miR-135b-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-27a-5p;hsa-miR-32-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-642a-5p;hsa-miR-769-3p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-93-3p 29 DLG2 Sponge network -6.51 0 -4.94 0.00023 0.365
41

GAS6-AS2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20b-5p;hsa-miR-429 10 FRMD6 Sponge network -1.941 0.0681 -1.608 0.08207 0.363
42 RP11-119F7.5 hsa-miR-135b-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-22-5p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-92b-3p 13 DLG2 Sponge network -2.406 0.03687 -4.94 0.00023 0.362
43

MIR143HG

 hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-2110;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-330-5p;hsa-miR-616-5p;hsa-miR-92a-3p 12 WNT5A Sponge network -6.51 0 -0.335 0.71496 0.356
44

RP11-389C8.2

 hsa-let-7g-3p;hsa-miR-130a-5p;hsa-miR-135b-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-330-3p;hsa-miR-33a-3p 16 DLG2 Sponge network -3.089 2.0E-5 -4.94 0.00023 0.355
45

MIR143HG

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 12 TGFBR2 Sponge network -6.51 0 -2.733 2.0E-5 0.353
46

DNM3OS

 hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-96-5p 11 LATS2 Sponge network -3.933 0.00059 -1.641 0.00068 0.348
47

MIR143HG

 hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 13 FZD4 Sponge network -6.51 0 -2.839 4.0E-5 0.346
48 CTB-92J24.3 hsa-let-7g-3p;hsa-miR-130a-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-33a-5p;hsa-miR-944 12 DLG2 Sponge network -7.226 0.0046 -4.94 0.00023 0.345
49

ACTA2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-708-5p 13 FZD4 Sponge network -6.142 0.00223 -2.839 4.0E-5 0.343
50

DNM3OS

 hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 13 FZD4 Sponge network -3.933 0.00059 -2.839 4.0E-5 0.341
51

EMX2OS

 hsa-miR-142-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-330-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-944 23 DLG2 Sponge network -6.205 0.00015 -4.94 0.00023 0.341
52

RP11-344E13.3

 hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p;hsa-miR-93-5p 11 BMPR2 Sponge network -4.307 3.0E-5 -1.126 0.00109 0.34
53

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-96-5p 18 CCND2 Sponge network -4.209 2.0E-5 -2.811 0.0014 0.339
54 RP11-819C21.1 hsa-miR-130a-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-185-5p;hsa-miR-22-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-590-3p 16 DLG2 Sponge network -1.571 0.00379 -4.94 0.00023 0.337
55 RP11-439M11.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p 10 CCND2 Sponge network -2.662 0.21003 -2.811 0.0014 0.337
56

DNM3OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 11 TGFBR2 Sponge network -3.933 0.00059 -2.733 2.0E-5 0.336
57 BDNF-AS hsa-miR-130a-5p;hsa-miR-142-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-29b-1-5p;hsa-miR-335-3p;hsa-miR-484;hsa-miR-590-3p 12 DLG2 Sponge network -1.712 0.02515 -4.94 0.00023 0.336
58

LINC00865

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-501-5p;hsa-miR-671-5p 12 FRMD6 Sponge network -1.585 0.19508 -1.608 0.08207 0.334
59

RP11-344E13.3

 hsa-let-7g-3p;hsa-miR-130a-3p;hsa-miR-135b-5p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-32-5p;hsa-miR-338-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-642a-5p;hsa-miR-877-5p;hsa-miR-93-3p 23 DLG2 Sponge network -4.307 3.0E-5 -4.94 0.00023 0.331
60 CTD-2554C21.3 hsa-miR-130a-3p;hsa-miR-130a-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19b-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-3613-5p;hsa-miR-484;hsa-miR-93-3p 16 DLG2 Sponge network -6.258 0.00703 -4.94 0.00023 0.33
61 NDUFA6-AS1 hsa-miR-130a-3p;hsa-miR-130a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-484;hsa-miR-582-5p;hsa-miR-590-5p;hsa-miR-877-5p 13 DLG2 Sponge network -1.026 0.04234 -4.94 0.00023 0.326
62 NR2F1-AS1 hsa-let-7g-3p;hsa-miR-130a-5p;hsa-miR-135b-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-32-5p;hsa-miR-484;hsa-miR-590-3p 18 DLG2 Sponge network -2.961 0.00154 -4.94 0.00023 0.323
63

RP11-166D19.1

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p 13 BMPR2 Sponge network -4.209 2.0E-5 -1.126 0.00109 0.321
64 RP11-116O18.1 hsa-let-7g-3p;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-590-3p;hsa-miR-590-5p 13 DLG2 Sponge network -5.007 0.06008 -4.94 0.00023 0.321
65

MIR497HG

 hsa-miR-130a-5p;hsa-miR-135b-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-33a-3p;hsa-miR-590-5p;hsa-miR-769-3p;hsa-miR-877-5p;hsa-miR-93-3p 21 DLG2 Sponge network -6.146 0.00024 -4.94 0.00023 0.32
66 RP11-359B12.2 hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-185-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-3613-5p;hsa-miR-484;hsa-miR-590-3p 13 DLG2 Sponge network -2.094 0.00033 -4.94 0.00023 0.32
67

HAND2-AS1

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 13 BMPR2 Sponge network -7.871 0 -1.126 0.00109 0.317
68 RP11-887P2.5 hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-3613-5p;hsa-miR-590-5p 14 DLG2 Sponge network -9.865 1.0E-5 -4.94 0.00023 0.316
69

MAGI2-AS3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-9-3p;hsa-miR-93-5p 19 CCND2 Sponge network -4.563 0 -2.811 0.0014 0.315
70

WT1-AS

 hsa-let-7g-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-3928-3p;hsa-miR-590-3p;hsa-miR-769-3p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-944 27 DLG2 Sponge network -6.875 2.0E-5 -4.94 0.00023 0.314
71

RP11-284N8.3

 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-93-5p;hsa-miR-96-5p 10 CCND2 Sponge network -0.845 0.52848 -2.811 0.0014 0.313
72

TPTEP1

 hsa-miR-142-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-32-5p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-590-3p;hsa-miR-92a-3p 12 DLG2 Sponge network -4.398 5.0E-5 -4.94 0.00023 0.312
73 RP11-130L8.1 hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-944 13 DLG2 Sponge network -4.329 1.0E-5 -4.94 0.00023 0.311
74

RP11-389C8.2

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-629-3p 12 FZD4 Sponge network -3.089 2.0E-5 -2.839 4.0E-5 0.311
75

FAM66C

 hsa-let-7g-3p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-32-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-3928-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p 26 DLG2 Sponge network -2.927 0.00012 -4.94 0.00023 0.311
76

MAGI2-AS3

 hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-2110;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30e-5p;hsa-miR-330-5p;hsa-miR-616-5p;hsa-miR-92a-3p 11 WNT5A Sponge network -4.563 0 -0.335 0.71496 0.31
77 USP3-AS1 hsa-miR-130a-5p;hsa-miR-135b-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-3p 16 DLG2 Sponge network -4.151 0 -4.94 0.00023 0.31
78

NR2F2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-5p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-452-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-708-5p 11 FZD4 Sponge network -3.785 0.00281 -2.839 4.0E-5 0.309
79 CTA-204B4.2 hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-15b-3p;hsa-miR-185-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-3613-5p 10 DLG2 Sponge network -1.612 0.00122 -4.94 0.00023 0.303
80

RP11-244O19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-30d-5p;hsa-miR-93-5p 10 FRMD6 Sponge network -1.318 0.0924 -1.608 0.08207 0.303
81 RP11-401P9.4 hsa-let-7g-3p;hsa-miR-135b-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-185-5p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-330-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484 15 DLG2 Sponge network -3.793 0.00144 -4.94 0.00023 0.302
82

MEG3

 hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-27a-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-93-3p;hsa-miR-944 13 DLG2 Sponge network -3.613 0.00075 -4.94 0.00023 0.302
83

GAS6-AS2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-429 14 CCND2 Sponge network -1.941 0.0681 -2.811 0.0014 0.301
84 PGM5-AS1 hsa-miR-130a-5p;hsa-miR-142-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-29b-1-5p;hsa-miR-33a-3p;hsa-miR-484 13 DLG2 Sponge network -14.107 0 -4.94 0.00023 0.301
85

DNM3OS

 hsa-let-7g-3p;hsa-miR-135b-5p;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-628-3p;hsa-miR-769-3p;hsa-miR-93-3p 25 DLG2 Sponge network -3.933 0.00059 -4.94 0.00023 0.298
86

RP11-597D13.9

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20b-5p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-93-5p 13 FRMD6 Sponge network -2.494 0.07597 -1.608 0.08207 0.297
87 RP11-13K12.1 hsa-miR-130a-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-944 14 DLG2 Sponge network -5.093 0.01151 -4.94 0.00023 0.295
88

RP11-389C8.2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p 17 CCND2 Sponge network -3.089 2.0E-5 -2.811 0.0014 0.293
89

SOCS2-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20b-5p;hsa-miR-3613-5p;hsa-miR-93-5p 11 FRMD6 Sponge network -4.167 1.0E-5 -1.608 0.08207 0.292
90

RP11-554A11.4

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p 10 CCND2 Sponge network -5.361 2.0E-5 -2.811 0.0014 0.29
91

MEG3

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-93-3p;hsa-miR-93-5p 10 BMPR2 Sponge network -3.613 0.00075 -1.126 0.00109 0.29
92 PSMD5-AS1 hsa-miR-130a-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-1-5p;hsa-miR-3613-5p;hsa-miR-484;hsa-miR-590-5p 11 DLG2 Sponge network -0.973 0.02357 -4.94 0.00023 0.29
93

TPTEP1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200c-3p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-629-3p 10 FZD4 Sponge network -4.398 5.0E-5 -2.839 4.0E-5 0.287
94

MIR143HG

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p 21 CCND2 Sponge network -6.51 0 -2.811 0.0014 0.285
95

MIR143HG

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 16 BMPR2 Sponge network -6.51 0 -1.126 0.00109 0.282
96 CTD-2554C21.2 hsa-let-7g-3p;hsa-miR-130a-3p;hsa-miR-130a-5p;hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-148b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-5p;hsa-miR-29b-3p;hsa-miR-944 17 DLG2 Sponge network -6.968 0.00817 -4.94 0.00023 0.279
97

RP11-344E13.3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-301a-3p;hsa-miR-30c-5p;hsa-miR-3613-5p;hsa-miR-454-3p;hsa-miR-671-5p;hsa-miR-93-5p 12 FRMD6 Sponge network -4.307 3.0E-5 -1.608 0.08207 0.276
98 RP11-981G7.6 hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-185-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-29b-1-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3928-3p;hsa-miR-484;hsa-miR-590-3p 11 DLG2 Sponge network -0.726 0.44765 -4.94 0.00023 0.274
99 CTA-109P11.4 hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-330-3p;hsa-miR-484 10 DLG2 Sponge network -7.746 0.00804 -4.94 0.00023 0.272
100

NR2F2-AS1

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 11 BMPR2 Sponge network -3.785 0.00281 -1.126 0.00109 0.265
101 CKMT2-AS1 hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-185-5p;hsa-miR-22-5p;hsa-miR-24-3p;hsa-miR-29b-1-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p 10 DLG2 Sponge network -1.384 0.001 -4.94 0.00023 0.265
102

SOCS2-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-93-5p 12 CCND2 Sponge network -4.167 1.0E-5 -2.811 0.0014 0.258
103

TRHDE-AS1

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 12 BMPR2 Sponge network -6.205 0.01165 -1.126 0.00109 0.257
104

RP11-389C8.2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-93-5p 10 TGFBR2 Sponge network -3.089 2.0E-5 -2.733 2.0E-5 0.253
105

RP11-597D13.9

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-96-5p 14 CCND2 Sponge network -2.494 0.07597 -2.811 0.0014 0.252
106

DNM3OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p;hsa-miR-96-5p 19 CCND2 Sponge network -3.933 0.00059 -2.811 0.0014 0.25

Quest ID: d66541f9337553cb2d031190626aa1da